<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Blue‐light filtering intraocular lenses (IOLs) for protecting macular health - Downie, LE - 2018 | Cochrane Library</title> <meta content="Blue‐light filtering intraocular lenses (IOLs) for protecting macular health - Downie, LE - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011977.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Blue‐light filtering intraocular lenses (IOLs) for protecting macular health - Downie, LE - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011977.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011977.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Blue‐light filtering intraocular lenses (IOLs) for protecting macular health" name="citation_title"/> <meta content="Laura E Downie" name="citation_author"/> <meta content="The University of Melbourne" name="citation_author_institution"/> <meta content="ldownie@unimelb.edu.au" name="citation_author_email"/> <meta content="Ljoudmila Busija" name="citation_author"/> <meta content="Australian Catholic University" name="citation_author_institution"/> <meta content="Peter R Keller" name="citation_author"/> <meta content="The University of Melbourne" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD011977.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/05/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011977.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011977.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011977.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Cataract Extraction [adverse effects, statistics &amp; numerical data]; *Lenses, Intraocular; *Light; Color; Contrast Sensitivity; Filtration [*instrumentation]; Macula Lutea [*radiation effects]; Macular Degeneration [*prevention &amp; control]; Postoperative Complications [*prevention &amp; control]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011977.pub2&amp;doi=10.1002/14651858.CD011977.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="9mpoajSI";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011977\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011977\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","pt","pl","fr","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011977.pub2",title:"Blue\\u2010light filtering intraocular lenses (IOLs) for protecting macular health",firstPublishedDate:"May 22, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011977.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011977.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011977.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011977.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011977.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011977.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011977.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011977.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011977.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011977.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10555 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011977.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-sec-0110"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-sec-0068"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-sec-0104"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/appendices#CD011977-sec-0115"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/table_n/CD011977StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/table_n/CD011977StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Blue‐light filtering intraocular lenses (IOLs) for protecting macular health</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/information#CD011977-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Laura E Downie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/information#CD011977-cr-0003">Ljoudmila Busija</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011977.pub2/information#CD011977-cr-0004">Peter R Keller</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/information/en#CD011977-sec-0125">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 May 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011977.pub2">https://doi.org/10.1002/14651858.CD011977.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011977-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011977-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011977-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011977-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011977-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011977-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011977-abs-0001" lang="en"> <section id="CD011977-sec-0001"> <h3 class="title" id="CD011977-sec-0001">Background</h3> <p>An intraocular lens (IOL) is a synthetic lens that is surgically implanted within the eye following removal of the crystalline lens, during cataract surgery. While all modern IOLs attenuate the transmission of ultra‐violet (UV) light, some IOLs, called blue‐blocking or blue‐light filtering IOLs, also reduce short‐wavelength visible light transmission. The rationale for blue‐light filtering IOLs derives primarily from cell culture and animal studies, which suggest that short‐wavelength visible light can induce retinal photoxicity. Blue‐light filtering IOLs have been suggested to impart retinal protection and potentially prevent the development and progression of age‐related macular degeneration (AMD). We sought to investigate the evidence relating to these suggested benefits of blue‐light filtering IOLs, and to consider any potential adverse effects. </p> </section> <section id="CD011977-sec-0002"> <h3 class="title" id="CD011977-sec-0002">Objectives</h3> <p>To assess the effects of blue‐light filtering IOLs compared with non‐blue‐light filtering IOLs, with respect to providing protection to macular health and function. </p> </section> <section id="CD011977-sec-0003"> <h3 class="title" id="CD011977-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2017, Issue 9); Ovid MEDLINE; Ovid Embase; LILACS; the ISRCTN registry; ClinicalTrials.gov and the ICTRP. The date of the search was 25 October 2017. </p> </section> <section id="CD011977-sec-0004"> <h3 class="title" id="CD011977-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs), involving adult participants undergoing cataract extraction, where a blue‐light filtering IOL was compared with an equivalent non‐blue‐light filtering IOL. </p> </section> <section id="CD011977-sec-0005"> <h3 class="title" id="CD011977-sec-0005">Data collection and analysis</h3> <p>The prespecified primary outcome was the change in distance best‐corrected visual acuity (BCVA), as a continuous outcome, between baseline and 12 months of follow‐up. Prespecified secondary outcomes included postoperative contrast sensitivity, colour discrimination, macular pigment optical density (MPOD), proportion of eyes with a pathological finding at the macula (including, but not limited to the development or progression of AMD, or both), daytime alertness, reaction time and patient satisfaction. We evaluated findings related to ocular and systemic adverse effects. </p> <p>Two review authors independently screened abstracts and full‐text articles, extracted data from eligible RCTs and judged the risk of bias using the Cochrane tool. We reached a consensus on any disagreements by discussion. Where appropriate, we pooled data relating to outcomes and used random‐effects or fixed‐effect models for the meta‐analyses. We summarised the overall certainty of the evidence using GRADE. </p> </section> <section id="CD011977-sec-0006"> <h3 class="title" id="CD011977-sec-0006">Main results</h3> <p>We included 51 RCTs from 17 different countries, although most studies either did not report relevant outcomes, or provided data in a format that could not be extracted. Together, the included studies considered the outcomes of IOL implantation in over 5000 eyes. The number of participants ranged from 13 to 300, and the follow‐up period ranged from one month to five years. Only two of the studies had a trial registry record and no studies referred to a published protocol. We did not judge any of the studies to have a low risk of bias in all seven domains. We judged approximately two‐thirds of the studies to have a high risk of bias in domains relating to ‘blinding of participants and personnel' (performance bias) and ‘blinding of outcome assessment' (detection bias). </p> <p>We found with moderate certainty, that distance BCVA with a blue‐light filtering IOL, at six to 18 months postoperatively, and measured in logMAR, was not clearly different to distance BCVA with a non‐blue‐light filtering IOL (mean difference (MD) ‐0.01 logMAR, 95% confidence interval (CI) ‐0.03 to 0.02, P = 0.48; 2 studies, 131 eyes). </p> <p>There was very low‐certainty evidence relating to any potential inter‐intervention difference for the proportion of eyes that developed late‐stage AMD at three years of follow‐up, or any stage of AMD at one year of follow‐up, as data derived from one trial and two trials respectively, and there were no events in either IOL intervention group, for either outcome. There was very low‐certainty evidence for the outcome for the proportion of participants who lost 15 or more letters of distance BCVA at six months of follow‐up; two trials that considered a total of 63 eyes reported no events, in either IOL intervention group. </p> <p>There were no relevant, combinable data available for outcomes relating to the effect on contrast sensitivity at six months, the proportion of eyes with a measurable loss of colour discrimination from baseline at six months, or the proportion of participants with adverse events with a probable causal link with the study interventions after six months. </p> <p>We were unable to draw reliable conclusions on the relative equivalence or superiority of blue‐light filtering IOLs versus non‐blue‐light filtering IOLs in relation to longer‐term effects on macular health. We were also not able to determine with any certainty whether blue‐light filtering IOLs have any significant effects on MPOD, contrast sensitivity, colour discrimination, daytime alertness, reaction time or patient satisfaction, relative to non‐blue‐light filtering IOLs. </p> </section> <section id="CD011977-sec-0007"> <h3 class="title" id="CD011977-sec-0007">Authors' conclusions</h3> <p>This systematic review shows with moderate certainty that there is no clinically meaningful difference in short‐term BCVA with the two types of IOLs. Further, based upon available data, these findings suggest that there is no clinically meaningful difference in short‐term contrast sensitivity with the two interventions, although there was a low level of certainty for this outcome due to a small number of included studies and their inherent risk of bias. Based upon current, best‐available research evidence, it is unclear whether blue‐light filtering IOLs preserve macular health or alter risks associated with the development and progression of AMD, or both. Further research is required to fully understand the effects of blue‐light filtering IOLs for providing protection to macular health and function. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011977-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011977-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011977-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011977-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011977-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011977-abs-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011977-abs-0009">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD011977-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011977-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011977-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011977-abs-0005" lang="en"> <h3>Artificial, blue‐light filtering lenses in the eye for protecting the macula (back of the eye) after cataract surgery </h3> <p><b>What is the aim of the review?</b><br/> The aim of this Cochrane Review was to find out if blue‐light filtering artifical lenses, also known as intraocular lenses (IOLs) protect the back of the eye. Cochrane Review authors collected and analysed all relevant studies to answer this question and found 51 studies. </p> <p><b>Key messages</b><br/> There is little evidence of any important differences between blue‐light filtering and non‐blue‐light filtering lenses. However, studies have been too small and too short‐term to provide a reliable answer to this question. </p> <p><b>What was studied in the review?</b><br/> Sometimes the lens in the eye becomes cloudy, often as people become older. Cataract surgery involves removing the cloudy lens and replacing it with an artificial one. This artificial lens is known as an 'intraocular lens' or IOL. These IOLs contain a filter to block harmful ultra‐violet (UV) light. Some lenses also have a filter to block visible blue light. In theory, high levels of blue light could damage the back of the eye that controls central vision (the macula). It has been suggested that blue‐light filtering IOLs may help to protect the macula and prevent a common cause of visual loss in older people, age‐related macular degeneration. </p> <p><b>What are the main results of the review?</b><br/> Cochrane Review authors included 51 studies from 17 different countries in this review. The review showed that: </p> <p>• there is probably no important difference in distance vision between blue‐light filtering artificial lenses and non‐blue‐light filtering lenses 12 months after surgery (we are moderately certain about this evidence);<br/> • there were no relevant data on contrast sensitivity (being a person's ability to differentiate an object from its background) and colour discrimination, being two measures of macular health;<br/> • none of the people taking part in these studies developed age‐related macular degeneration within the follow‐up period (we are very uncertain about this evidence);<br/> • there was no evidence on adverse outcomes that may be related to the blue‐light filtering IOLs (for example, sleep disturbance). </p> <p><b>How up‐to‐date is this review?</b><br/> Cochrane Review authors searched for studies that had been published up to 25 October 2017. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011977-sec-0110" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011977-sec-0110">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011977-sec-0172">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011977-sec-0110"></div> <h3 class="title" id="CD011977-sec-0111">Implications for practice</h3> <section id="CD011977-sec-0111"> <p>Based upon our consideration of the current, best‐available clinical research evidence, this systematic review shows, with moderate certainty (using the GRADE approach), that there is no clinically meaningful difference in short‐term (three to 18 months postoperative) BCVA with blue‐light filtering and non‐blue‐light filtering IOLs. With regard to effects on other visual performance measures, based upon available data, our findings suggest that there is no clinically meaningful difference in short‐term (three to six months postoperative) contrast sensitivity with the two interventions, although there was a low level of certainty for this outcome due to a small number of included studies and their inherent risk of bias. There were no relevant data relating to the proportion of participants with adverse events with a probably casual link with the study interventions after six months of follow‐up. </p> <p>Whether blue‐light filtering IOLs preserve macular health or alter the risks associated with the development and progression of AMD, or both, are currently unclear (i.e. there was very low‐certainty evidence); the use of blue‐light filtering IOLs for this specific purpose, in clinical practice, is therefore speculative and claims regarding macular protection are not currently justified by the best available evidence. Due to an insufficient number of studies reporting on these outcomes or variability in the methods used to quantify the outcome(s), or both, we were unable to ascertain with any certainty whether blue‐light filtering IOLs have any significant effects on MPOD, colour discrimination, daytime alertness, reaction time or patient satisfaction. </p> </section> <h3 class="title" id="CD011977-sec-0112">Implications for research</h3> <section id="CD011977-sec-0112"> <p>The question relating to whether blue‐light filtering IOLs protect macular health is a global public health issue. AMD is one of the leading causes of visual impairment worldwide, and effective methods for preventing its development and progression would be anticipated to have substantial benefits in terms of decreasing the individual and community burden of the disease. </p> <p>The present review, which considered the best‐available research evidence relating to the potential benefits of blue‐light filtering IOLs for protecting macular health, showed that there is insufficient evidence to support the prescription of these devices for the purpose of preserving macular integrity and altering the risks associated with the development or progression of AMD. This largely reflects that many studies only considered vision performance measures (e.g. BCVA and contrast sensitivity) over relatively short postoperative follow‐up periods (i.e. up to 12 months). There is therefore currently a need for adequately‐powered, well‐designed, long‐term (i.e., over several years) clinical trials to evaluate whether blue‐light filtering IOLs are beneficial for preserving macular integrity. Ideally, future trials should consider whether the extent of environmental blue‐light exposure and/or the degree of blue‐light attenuation within the IOL affects clinical outcomes. Furthermore, there is a need for trials to investigate whether the potential benefit of a blue‐light filtering IOL differs between individuals with a healthy macula at baseline, versus those with early‐stage macular disease or a known risk of disease development (e.g., genetic risk factors or tobacco‐smoking risk factors for AMD); this information could be used to inform whether the potential benefits of blue‐light filtering IOL are stratified by patient population. </p> <p>A further consideration relates to the design of future clinical trials in this field. Many of the included RCTs excluded participants who experienced intraoperative or postoperative complications. In order to ensure the accuracy of the reported outcome data and to reduce the potential for an underestimation of adverse effects from the interventions, we recommend that future trials describe the outcomes for all randomised participants, using an intention‐to‐treat analysis approach. Furthermore, to enable the outcomes reported in different studies to be more readily compared (and pooled in meta‐analyses, as appropriate), an agreed set of outcomes, known as a 'core outcome set', as recommended by the COMET initiative (<a href="./references#CD011977-bbs2-0136" title="PrinsenCA , VohraS , RoseMR , King‐JonesS , IshaqueS , BhalooZ , et al. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a ‘core outcome set’. Trials2014;15:247. ">Prinsen 2014</a>), would be valuable. Such an approach would be useful for outcomes such as for colour discrimination, where there is still uncertainty about the potential effects of blue‐light filtering IOLS, and where we observed significant heterogeneity between studies in relation to its measurement and reporting. Another example where an agreed set of core outcomes would be advantageous relates to the detection of changes in macular integrity. With the advent of non‐invasive, high‐resolution retinal imaging modalities, such as optical coherence tomography (OCT), it may be possible to define a range of meaningful surrogate outcome measures that could have greater sensitivity for detecting changes to macular health than traditional retinal fundus photography. </p> <p>Another area requiring consideration by future clinical trial researchers relates to the adoption of appropriate statistical approaches for analysing paired‐eye and bilateral eye studies. None of the included studies reported appropriate methods for considering within‐patient correlations, which may have resulted in biased estimates of effects in these studies. </p> <p>The results of this review therefore encourage the conduct of future high‐quality research, factoring in the points described, to assess the effects of blue‐light filtering IOLs compared with non‐blue‐light filtering IOLs for providing long‐term protection to macular health and function. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011977-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011977-sec-0036"></div> <div class="table" id="CD011977-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Blue‐light filtering intraocular lenses (IOL) compared to non blue‐light filtering IOL for protecting macular health</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Blue‐light filtering IOL compared to non‐blue‐light filtering IOL for protecting macular health</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults undergoing cataract surgery with IOL implantation<br/> <b>Setting:</b> eye hospitals<br/> <b>Intervention:</b> blue‐light filtering IOL<br/> <b>Comparison:</b> non‐blue‐light filtering IOL </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with non‐blue‐light filtering IOL</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with blue‐light filtering IOL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in distance BCVA, between baseline and 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in distance BCVA between baseline and 12 months was 0 logMAR</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 logMAR lower<br/> (0.03 lower to 0.02 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>131<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower BCVA (in logMAR) indicates a higher level of visual acuity. Studies in this analysis reported data at the end of the follow‐up period rather than change from baseline. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Distance BCVA, considered as a dichotomous outcome (being the proportion of eyes that experienced loss of 15 or more letters from baseline BCVA), at six months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no eyes, in either intervention group that had a loss of 15 or more letters from baseline BCVA. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Contrast sensitivity function, measured in log Contrast Sensitivity at six months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relevant combinable data available for this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colour discrimination, measured as the proportion of eyes that had a measurable loss from baseline using Farnsworth‐Munsell 100‐hue colour test score under photopic conditions at six months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relevant combinable data available for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants with adverse events with a probable causal link with the study interventions at six months follow‐up </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No relevant combinable data available for this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of eyes that developed late‐stage AMD, being CNV and/or GA, at three years of follow‐up </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the 1 trial (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>) there were no eyes, in either intervention group that developed late‐stage AMD at five years of follow‐up. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of eyes that developed any stage of AMD at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>144<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In both studies, there were no eyes, in either intervention group that developed any stage of AMD over the nominated follow‐up period. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>AMD</b> : age‐related macular degeneration; <b>BCVA</b> : best‐corrected visual acuity; <b>CI:</b> confidence interval; <b>CNV</b> : choroidal neovascularisation; <b>GA</b> : geographic atrophy; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High‐certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate‐certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low‐certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low‐certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded for risk of bias (‐1). Data derive from two relatively small studies, with one (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>) judged to have a high risk of bias in both masking domains, and the other (<a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>) having an unclear risk of bias in most domains.<br/> <sup>b</sup>Downgraded for imprecision (‐2). <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a> excluded participants with surgical or postoperative complications, including vitreous loss, capsule tears or prolonged intraocular inflammation from the analysis, and hence did not capture these outcomes (which may affect BCVA) in this study. In addition, there were no events in either study group.<br/> <sup>c</sup>Downgraded for risk of bias (‐1). Data derive from two relatively small studies (<a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>), which both had an unclear risk of bias in at least three key domains.<br/> <sup>d</sup>Downgraded for risk of bias (‐1) and imprecision (‐2). Data derive from one small trial involving 60 participants (<a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>), with an unknown risk of bias in multiple domains. In this trial, there were no events in either study group.<br/> <sup>e</sup>Downgraded for risk of bias (‐2) and imprecision (‐1). Data derive from two small trials (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>). The <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a> study has an unknown risk of bias in multiple domains, and we judged <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a> as having a high risk of bias in multiple domains, including performance bias and detection bias. In both trials, there were no events in either study group. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011977-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011977-sec-0037">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011977-sec-0135">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011977-sec-0037"></div> <section id="CD011977-sec-0038"> <h3 class="title" id="CD011977-sec-0038">Description of the condition</h3> <p>The macula is the specialised region of the human retina that mediates the central 15 to 20 degrees of vision (<a href="./references#CD011977-bbs2-0115" title="HolzFG , PauleikhoffD , SpaideRF , BirdAC . Age‐related Macular Degeneration. Berlin: Springer‐Verlag, 2013. ">Holz 2013</a>). Anatomically, the macula corresponds to an area of approximately 5 mm in diameter within the posterior pole (<a href="./references#CD011977-bbs2-0142" title="SnellRS , LempMA . Clinical Anatomy of the Eye. Oxford: Blackwell Science, 1998. ">Snell 1998</a>) and has a distinctive yellow pigmentation resulting from the presence of the carotenoid pigments, lutein and zeaxanthin (<a href="./references#CD011977-bbs2-0089" title="BeattyS , BoultonM , HensonD , KohHH , MurrayIJ . Macular pigment and age related macular degeneration. British Journal of Ophthalmology1999;83(7):867‐77. ">Beatty 1999</a>; <a href="./references#CD011977-bbs2-0147" title="WaldG . Human vision and the spectrum. Science1945;101(2635):653‐8. ">Wald 1945</a>). The macular pigments are thought to protect against the hazards of short‐wavelength visible light, which includes violet and blue light. Functionally, the macula enables high‐resolution spatial vision and colour perception. The maintenance of macular health is essential to normal visual function. It follows that diseases adversely affecting the macula can lead to significant vision impairment. In 2010, 2.1 million people globally were blind and 6.0 million people were visually impaired due to macular diseases (<a href="./references#CD011977-bbs2-0116" title="JonasJB , BourneRR , WhiteRA , FlaxmanSR , KeeffeJ , LeasherJ , et al. Visual impairment and blindness due to macular diseases globally: a systematic review and meta‐analysis. American Journal of Ophthalmology2014;158(4):808‐15. ">Jonas 2014</a>). </p> <p>A common form of macular disease is age‐related macular degeneration (AMD), which is a leading cause of blindness in developed countries (<a href="./references#CD011977-bbs2-0099" title="CongdonN , O'ColmainB , KlaverCC , KleinR , MunozB , FriedmanDS , et al. Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology2004;122(4):477‐85. ">Congdon 2004</a>; <a href="./references#CD011977-bbs2-0135" title="PascoliniD , MariottiSP . Global estimates of visual impairment: 2010. British Journal of Ophthalmology2012;95(5):614‐8. ">Pascolini 2012</a>). AMD is a slowly progressive retinal degenerative condition that selectively affects the macula and, thereby, central vision. The prevalence of AMD increases dramatically with age (<a href="./references#CD011977-bbs2-0133" title="OwenCG , FletcherAE , DonoghueM , RudnickaAR . How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?. British Journal of Ophthalmology2003;87(3):312‐7. ">Owen 2003</a>; <a href="./references#CD011977-bbs2-0148" title="WongWL , SuX , LiX , CheungCM , KleinR , ChengCY , et al. Global prevalence of age‐related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta‐analysis. Lancet Global Health2014;2(2):e106‐16. ">Wong 2014</a>). Approximately one‐third of people aged 80 years or over are likely to show clinical signs of AMD (<a href="./references#CD011977-bbs2-0117" title="KleinR , KleinBE , LintonKL . Prevalence of age‐related maculopathy. The Beaver Dam Eye Study. Ophthalmology1992;99(6):933‐43. ">Klein 1992</a>), with about 6% of people having late‐stage disease by this age (<a href="./references#CD011977-bbs2-0138" title="RudnickaAR , JarrarZ , WormaldR , CookDG , FletcherA , OwenCG . Age and gender variations in age‐related macular degeneration prevalence in populations of European ancestry: a meta‐analysis. Ophthalmology2012;119(3):571‐80. ">Rudnicka 2012</a>). Established risks for AMD include increasing age, genetic factors (<a href="./references#CD011977-bbs2-0119" title="KleinRJ , ZeissC , ChewEY , TsaiJY , SacklerRS , HaynesC , et al. Complement factor H polymorphism in age‐related macular degeneration. Science2005;308(5720):358‐9. ">Klein 2005</a>; <a href="./references#CD011977-bbs2-0150" title="YangZ , CampNJ , SunH , TongZ , GibbsD , CameronDJ , et al. A variant of the HTRA1 gene increases susceptibility to age‐related macular degeneration. Science2006;314(5801):992‐3. ">Yang 2006</a>) and smoking (<a href="./references#CD011977-bbs2-0145" title="ThorntonJ , EdwardsR , MitchellP , HarrisonRA , BuchanI , KellySP . Smoking and age‐related macular degeneration: a review of association. Eye2005;19(9):935‐44. ">Thornton 2005</a>). It has been hypothesised, but remains unclear, whether other factors, including long‐term exposure to environmental short‐wavelength light, contribute to AMD (<a href="./references#CD011977-bbs2-0089" title="BeattyS , BoultonM , HensonD , KohHH , MurrayIJ . Macular pigment and age related macular degeneration. British Journal of Ophthalmology1999;83(7):867‐77. ">Beatty 1999</a>). </p> <p>AMD is typically asymptomatic in its early stages. Clinically, a key retinal sign is the appearance of drusen, visible as amorphous yellow deposits between the retinal pigment epithelium (RPE) and Bruch’s membrane, which result from the deposition of lipoproteineous material (<a href="./references#CD011977-bbs2-0093" title="BresslerNM , SilvaJC , BresslerSB , FineSL , GreenWR . Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age‐related macular degeneration. Retina1994;14(2):130‐42. ">Bressler 1994</a>; <a href="./references#CD011977-bbs2-0139" title="SarksSH , ArnoldJJ , KillingsworthMC , SarksJP . Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. British Journal of Ophthalmology1999;83(3):358‐68. ">Sarks 1999</a>). The presence of large drusen and hyper‐ or hypo‐pigmentary changes, or both, within the macula, confers a higher risk of progression to late‐stage AMD (<a href="./references#CD011977-bbs2-0106" title="FerrisFL , DavisMD , ClemonsTE , LeeLY , ChewEY , LindbladAS , et al. A simplified severity scale for age‐related macular degeneration: AREDS Report No. 18. Archives of Ophthalmology2005;123(11):1570‐4. ">Ferris 2005</a>). Progressive disease may result in the development of geographic atrophy and/or choroidal neovascularisation (CNV); both of these forms of late‐stage AMD pose a high risk of significant vision loss. </p> <p>High‐contrast visual acuity is currently the most consistently reported measure of visual function in studies of AMD, but is a relatively insensitive tool (<a href="./references#CD011977-bbs2-0103" title="DownieLE , KellerPR . Nutrition and age‐related macular degeneration: research evidence in practice. Optometry and Vision Science2014;91(8):821‐31. ">Downie 2014a</a>). A range of other functional measures have also been shown to be affected in AMD; these include static and flicker perimetry (<a href="./references#CD011977-bbs2-0123" title="LuuCD , DimitrovPN , WuZ , AytonLN , MakeyevaG , AungKZ , et al. Static and flicker perimetry in age‐related macular degeneration. Investigative Ophthalmology and Visual Science2013;54(5):3560‐8. ">Luu 2013</a>), microperimetry (<a href="./references#CD011977-bbs2-0149" title="WuZ , AytonLN , GuymerRH , LuuCD . Intrasession test‐retest variability of microperimetry in age‐related macular degeneration. Investigative Ophthalmology and Visual Science2013;54(12):7378‐85. ">Wu 2013</a>), colour vision (<a href="./references#CD011977-bbs2-0104" title="DownieLE , ChengAS , VingrysAJ . Color vision deficits in intermediate age‐related macular degeneration. Optometry and Vision Science2014;91(8):932‐8. ">Downie 2014b</a>) and the multifocal electroretinogram (<a href="./references#CD011977-bbs2-0107" title="GinTJ , LuuCD , GuymerRH . Central retinal function as measured by the multifocal electroretinogram and flicker perimetry in early age‐related macular degeneration. Investigative Ophthalmology and Visual Science2011;52(12):9267‐74. ">Gin 2011</a>). </p> <p>There is currently no intervention for preventing the development of AMD, nor a cure for AMD. Although treatments, in the form of intra‐vitreal vascular endothelial growth factor inhibitors, exist for CNV, at present therapeutic treatments for early stages of AMD, or geographic atrophy, are still considered to be experimental. Given that AMD is the leading cause of irreversible vision impairment in people aged 50 years or older in developed countries (<a href="./references#CD011977-bbs2-0098" title="ColemanH , ChanC , FerrisFL . Age‐related macular degeneration. Lancet2008;372(9652):1835‐45. ">Coleman 2008</a>), there is great interest in interventions that can be used to prevent the development of AMD or delay progression to late‐stage AMD. </p> </section> <section id="CD011977-sec-0039"> <h3 class="title" id="CD011977-sec-0039">Description of the intervention</h3> <p>Sunlight is composed of electromagnetic radiation that ranges from ultraviolet (UV) through to infrared (IR) light. UV radiation involves wavelengths in the 200 to 400 nanometre (nm) range (<a href="./references#CD011977-bbs2-0151" title="YoussefPN , SheibaniN , AlbertDM . Retinal light toxicity. Eye2011;25:1‐14. ">Youssef 2011</a>). Visible light is in the 380 to 760 nm range; short‐wavelength visible light (400 to 500 nm) corresponds to the violet (400 to 440 nm) and blue (440 to 500 nm) colours within the visible spectrum (<a href="./references#CD011977-bbs2-0126" title="MainsterMA . Intraocular lenses should block UV radiation and violet but not blue light. Archives of Ophthalmology2005;123(4):550‐5. ">Mainster 2005</a>). Modern technological devices, such as light emitting diodes (LEDs) and compact fluorescent lamps (CFLs) also emit relatively high levels of blue light. </p> <p>Blue‐light filtering, also termed ‘blue‐blocking’, ophthalmic lenses are lenses that are designed to selectively attenuate the transmission of UV radiation and short‐wavelength visible light (<a href="./references#CD011977-bbs2-0127" title="MainsterMA . Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. British Journal of Ophthalmology2006;90(6):784‐92. ">Mainster 2006</a>). They were first introduced into ophthalmologic practice in 1991. Two main categories of blue‐light filtering ophthalmic lens products are currently commercially available, being intraocular lenses (IOLs) and spectacle lenses; this review focusses specifically on IOLs. Spectacle lens filters have been considered elsewhere (<a href="./references#CD011977-bbs2-0105" title="DownieLE . Blue‐light filtering ophthalmic lenses: to prescribe, or not to prescribe?. Ophthalmic and Physiological Optics2017;37(6):640‐3. ">Downie 2017</a>; <a href="./references#CD011977-bbs2-0120" title="LawrensonJG , HullCH , DownieLE . The effect of blue‐light blocking spectacle lenses on visual performance, macular health and the sleep‐wake cycle: a systematic review of the literature. Ophthalmic and Physiological Optics2017;37(6):644‐54. ">Lawrenson 2017</a>). </p> <p>An IOL is a synthetic lens that is surgically implanted within the eye following removal of the natural crystalline lens, during cataract surgery. Blue‐blocking IOLs typically contain yellow chromophores that attenuate the transmission of about half of incident short‐wavelength light, depending upon their dioptric power (<a href="./references#CD011977-bbs2-0094" title="BrockmannC , SchulzM , LaubeT . Transmittance characteristics of ultraviolet and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(7):1161‐6. ">Brockmann 2008</a>; <a href="./references#CD011977-bbs2-0127" title="MainsterMA . Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. British Journal of Ophthalmology2006;90(6):784‐92. ">Mainster 2006</a>). Blue‐blocking IOLs contrast with UV‐blocking IOLs, which are colourless and absorb most UV radiation and a small amount of violet light (<a href="./references#CD011977-bbs2-0125" title="MainsterMA . The spectra, classification, and rationale of ultraviolet‐protective intraocular lenses. American Journal of Ophthalmology1986;102(6):727‐32. ">Mainster 1986</a>; <a href="./references#CD011977-bbs2-0127" title="MainsterMA . Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. British Journal of Ophthalmology2006;90(6):784‐92. ">Mainster 2006</a>). A range of blue‐blocking IOLs are currently available on the market; examples include the OptiBlue (AMO), AF‐1 (Hoya), AcrySof Natural (Alcon) and PC 440Y Orange Series (Optech). </p> </section> <section id="CD011977-sec-0040"> <h3 class="title" id="CD011977-sec-0040">How the intervention might work</h3> <p>While light is essential to visual perception, it is also a potential ocular hazard. Fortunately, the natural absorbance characteristics of the anterior structures of the eye limit the amount of potentially damaging UV radiation that reaches the retina. The cornea absorbs UV radiation below 300 nm (<a href="./references#CD011977-bbs2-0091" title="BoettnerEA , WalterJR . Transmission of the ocular media. Investigative Ophthalmology and Visual Science1962;1:766‐83. ">Boettner 1962</a>) and the crystalline lens blocks most light between 300 nm and 400 nm (<a href="./references#CD011977-bbs2-0091" title="BoettnerEA , WalterJR . Transmission of the ocular media. Investigative Ophthalmology and Visual Science1962;1:766‐83. ">Boettner 1962</a>; <a href="./references#CD011977-bbs2-0132" title="NorrenDV , VosJJ . Spectral transmission of the human ocular media. Vision Research1974;14(11):1237‐44. ">Norren 1974</a>). The crystalline lens becomes progressively less transparent and more yellowed with age; the result of this physiological process is a relative reduction in the transmittance of short‐wavelength visible light to the retina (<a href="./references#CD011977-bbs2-0146" title="VanNorrenD , Van deKraatsJ . Spectral transmission of intraocular lenses expressed as a virtual age. British Journal of Ophthalmology2007;91(10):1374‐5. ">Van Norren 2007</a>). The aged crystalline lens therefore demonstrates blue‐light filtering properties, whereas younger crystalline lenses allow more short‐wavelength visible light to be transmitted to the retina. It has been suggested that following cataract surgery, the implantation of an IOL that enables relatively greater transmittance of short‐wavelength visible light than the aged crystalline lens, could precipitate retinal dysfunction, in particular AMD; there are insufficient data currently to support this suggestion (<a href="./references#CD011977-bbs2-0095" title="CasparisH , LindsleyK , KuoIC , SikderS , BresslerNM . Surgery for cataracts in people with age‐related macular degeneration. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD006757.pub3] ">Casparis 2012</a>). The relative vulnerability of the younger eye to retinal damage due to the natural transmittance of blue light has also been raised. </p> <p>Blue‐light filtering ophthalmic lenses are proposed to protect against potential light‐induced retinal damage, a phenomenon known as retinal phototoxicity, which may arise from short‐wavelength visible light. Laboratory studies have shown that retinal phototoxicity is commonly due to photochemical damage (<a href="./references#CD011977-bbs2-0151" title="YoussefPN , SheibaniN , AlbertDM . Retinal light toxicity. Eye2011;25:1‐14. ">Youssef 2011</a>), which occurs when light is absorbed by a photosensitiser (a chromophore) and reactive oxygen species (ROS) are liberated (<a href="./references#CD011977-bbs2-0092" title="BoultonM , RozanowskaM , RozanowskiB . Retinal photodamage. Journal of Photochemistry and Photobiology. B, Biology2001;64(2‐3):144‐61. ">Boulton 2001</a>). ROS can induce cytotoxic retinal damage through various processes, including lipid peroxidation, protein oxidation and mutagenesis (<a href="./references#CD011977-bbs2-0092" title="BoultonM , RozanowskaM , RozanowskiB . Retinal photodamage. Journal of Photochemistry and Photobiology. B, Biology2001;64(2‐3):144‐61. ">Boulton 2001</a>). Although the retina has cellular defence mechanisms to combat ROS, for various reasons the efficiency of these compensatory processes typically decline with age (<a href="./references#CD011977-bbs2-0130" title="MargrainTH , BoultonM , MarshallJ , SlineyDH . Do blue light filters confer protection against age‐related macular degeneration?. Progress in Retinal and Eye Research2004;23(5):523‐31. ">Margrain 2004</a>). The highly oxygenated outer retinal layers, in particular the RPE and photoreceptors, are considered most vulnerable to photochemical damage. Under experimental conditions, short‐wavelength visible light has been shown to induce cellular damage to the RPE (<a href="./references#CD011977-bbs2-0110" title="HamWTJr , RuffoloJJJr , MuellerHA , ClarkeAM , MoonME . Histologic analysis of photochemical lesions produced in rhesus retina by short‐wave‐length light. Investigative Ophthalmology and Visual Science1978;17(10):1029‐35. ">Ham 1978</a>; <a href="./references#CD011977-bbs2-0111" title="HamWTJr , MuellerHA , RuffoloJJJr , MillenJE , ClearySF , GuerryRK , et al. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Current Eye Research1984;3(1):165‐74. ">Ham 1984</a>); this region of the visible spectrum has the most potential for retinal phototoxicity (<a href="./references#CD011977-bbs2-0109" title="HamWTJr , MuellerHA , SlineyDH . Retinal sensitivity to damage from short wavelength light. Nature1976;260:153‐5. ">Ham 1976</a>), which forms the basis for the commonly‐adopted phrase, ‘blue light hazard’ (<a href="./references#CD011977-bbs2-0092" title="BoultonM , RozanowskaM , RozanowskiB . Retinal photodamage. Journal of Photochemistry and Photobiology. B, Biology2001;64(2‐3):144‐61. ">Boulton 2001</a>). Although the precise intracellular chromophore(s) that mitigate the reported blue‐light sensitivity of RPE cells is not certain, the lipofuscin component A2E has been proposed to be a likely candidate. This fluorophore is found specifically in RPE cells and accumulates with age (<a href="./references#CD011977-bbs2-0134" title="ParishCA , HashimotoM , NakanishiK , DillonJ , SparrowJ . Isolation and one‐step preparation of A2E and iso‐A2E, fluorophores from human retinal pigment epithelium. Proceedings of the National Academy of Sciences of the United States of America1998;95(25):14609‐13. ">Parish 1998</a>); the absorbance spectrum for lipofuscin also mirrors the action spectra for blue‐light phototoxicity (<a href="./references#CD011977-bbs2-0128" title="MainsterMA , TurnerPL . Blue‐blocking IOLs decrease photoreception without providing significant photoprotection. Survey of Ophthalmology2010;55(3):272‐89. ">Mainster 2010</a>). </p> <p>Based mostly on evidence from animal studies, it has been hypothesised that cumulative retinal damage in humans, due to phototoxicity from environmental light exposure (<a href="./references#CD011977-bbs2-0124" title="MainsterMA . Solar retinitis, photic maculopathy and the pseudophakic eye. Journal of the American Intra‐Ocular Implant Society1978;4(3):84‐6. ">Mainster 1978</a>), may contribute to the macular changes that occur in AMD. Based upon this hypothesis, blue‐light filtering ophthalmic lenses have been suggested to have a role in protecting the macula and possibly preventing the development or progression of AMD, or both (<a href="./references#CD011977-bbs2-0089" title="BeattyS , BoultonM , HensonD , KohHH , MurrayIJ . Macular pigment and age related macular degeneration. British Journal of Ophthalmology1999;83(7):867‐77. ">Beatty 1999</a>; <a href="./references#CD011977-bbs2-0090" title="BernsteinPS , DeloriFC , RicherS , VanKujikFJ , WenzelAJ . The value of measurement of macular carotenoid pigment optical densities and distributions in age‐related macular degeneration and other retinal disorders. Vision Research2010;50(7):716‐28. ">Bernstein 2010</a>). Concerns regarding the possible disruption of circadian rhythms, to affect sleep quality and daytime alertness, by blue‐light filtering ophthalmic lenses remain controversial (<a href="./references#CD011977-bbs2-0127" title="MainsterMA . Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. British Journal of Ophthalmology2006;90(6):784‐92. ">Mainster 2006</a>). </p> </section> <section id="CD011977-sec-0041"> <h3 class="title" id="CD011977-sec-0041">Why it is important to do this review</h3> <p>While the rationale for blue‐light filtering ophthalmic lenses is scientifically plausible, there is significant academic debate with regard to the merit, or otherwise, of these ophthalmic devices for protecting the macula (<a href="./references#CD011977-bbs2-0121" title="LeeRM , LamFC , LiuCS . Blue‐blocking intraocular implants should be used routinely during phacoemulsification surgery ‐ No. Eye2012;26:1400‐1. ">Lee 2012</a>; <a href="./references#CD011977-bbs2-0129" title="MainsterMA , TurnerPL . Blue‐blocking IOLs vs. short‐wavelength visible light: hypothesis‐based vs. evidence‐based medical practice. Ophthalmology2011;118(1):1‐2. ">Mainster 2011</a>; <a href="./references#CD011977-bbs2-0144" title="SymesRJ , CuthbertsonFM . Blue‐blocking intraocular implants should be used routinely during phacoemulsification surgery‐‐yes. Eye2012;26(11):1397‐9. ">Symes 2012</a>). This is due, at least in part, to apparently contradictory evidence relating to their merit, and creates potential confusion for eye care practitioners seeking to provide best‐practice care. </p> <p>Blue‐blocking IOLs are routinely used for cataract surgery, accounting for approximately 25% of IOLs implanted worldwide (<a href="./references#CD011977-bbs2-0129" title="MainsterMA , TurnerPL . Blue‐blocking IOLs vs. short‐wavelength visible light: hypothesis‐based vs. evidence‐based medical practice. Ophthalmology2011;118(1):1‐2. ">Mainster 2011</a>). This is despite the relative paucity of epidemiological evidence to corroborate the postulated benefit of blue‐blocking lenses for macular protection; 10 of the 12 major population‐based studies that sought to determine whether there was a correlation between light exposure and AMD did not report a positive association (<a href="./references#CD011977-bbs2-0127" title="MainsterMA . Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. British Journal of Ophthalmology2006;90(6):784‐92. ">Mainster 2006</a>). Similarly inconclusive are studies that have sought to determine whether cataract surgery is a risk factor for the development or progression of AMD; while some studies have reported positive associations (<a href="./references#CD011977-bbs2-0118" title="KleinR , KleinBE , JensenSC , CruickshanksKJ . The relationship of ocular factors to the incidence and progression of age‐related maculopathy. Archives of Ophthalmology1998;116(4):506‐13. ">Klein 1998</a>; <a href="./references#CD011977-bbs2-0122" title="LiuIY , WhiteL , LaCroixAZ . The association of age‐related macular degeneration and lens opacities in the aged. American Journal of Public Health1989;79(6):765‐9. ">Liu 1989</a>), others have found no clear effects upon AMD progression (<a href="./references#CD011977-bbs2-0088" title="BaatzH , DarawshaR , AckermannH , SchariothGB , deOrtuetaD , PavlidisM , et al. Phacoemulsification does not induce neovascular age‐related macular degeneration. Investigative Ophthalmology and Visual Science2008;49(3):1079‐83. ">Baatz 2008</a>; <a href="./references#CD011977-bbs2-0097" title="ChewEY , SperdutoRD , MiltonRC , ClemonsTE , GenslerGR , BresslerSB , et al. Risk of advanced age‐related macular degeneration after cataract surgery in the Age‐Related Eye Disease Study: AREDS report 25. Ophthalmology2009;116(2):297‐303. ">Chew 2009</a>). Importantly, observational studies have acknowledged methodological limitations, including the potential influences of bias and confounding, which can limit the interpretation of their findings. </p> <p>Whether blue‐light filtering lenses protect macular health is a major public health issue. AMD is a leading cause of blindness worldwide, and effective methods for preventing its development or progression would be expected to have immense benefits in reducing the individual and economic burden of this disease. The relevance of these potential gains is heightened in the context of global demographic shifts toward enhanced longevity. A systematic review, considering the best‐available research evidence, is essential to objectively evaluate the relative appropriateness of current practices in relation to the prescription of blue‐light filtering ophthalmic lenses. Such an evaluation considers both the relative benefits and potential harms of these devices. We consider this topic to be of significant interest to clinicians, researchers and the wider community. The undertaking of this systematic review may also identify areas of focus for future research in the field. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011977-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011977-sec-0042">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011977-sec-0140">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011977-sec-0042"></div> <p>To assess the effects of blue‐light filtering IOLs compared with non‐blue‐light filtering IOLs, with respect to providing protection to macular health and function. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011977-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011977-sec-0043">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011977-sec-0141">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011977-sec-0043"></div> <section id="CD011977-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011977-sec-0045"> <h4 class="title">Types of studies</h4> <p>We considered randomised controlled trials (RCTs) only.</p> </section> <section id="CD011977-sec-0046"> <h4 class="title">Types of participants</h4> <p>We included RCTs in which the participants were adults (i.e., at least 18 years of age). </p> </section> <section id="CD011977-sec-0047"> <h4 class="title">Types of interventions</h4> <p>We included RCTs that compared a blue‐light filtering IOL with an equivalent type of non‐blue‐light filtering IOL. We did not include studies that used blue‐light filtering IOLs in combination with any other potential intervention for AMD. </p> </section> <section id="CD011977-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD011977-sec-0049"> <h5 class="title">Primary outcomes</h5> <p>The prespecified primary outcome was the change in distance best‐corrected visual acuity (BCVA), considered as a continuous outcome, between baseline and 12 months of follow‐up. For this outcome, we accepted BCVA measures between six and 18 months of follow‐up. If studies did not report the change in distance BCVA, we utilised data reported at the end of the follow‐up period. </p> </section> <section id="CD011977-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p>We considered the following secondary outcomes:</p> <p> <ul id="CD011977-list-0001"> <li> <p>proportion of eyes with late‐stage AMD, being neovascular AMD or geographic atrophy as defined by the study investigators, at three years of follow‐up (with an acceptable follow‐up range of between two and four years); </p> </li> <li> <p>proportion of eyes with any stage of AMD, as defined by the study investigators, at 12 months (with an acceptable follow‐up range of between six and 18 months); </p> </li> <li> <p>proportion of eyes with a finding of pathological structural change at the macula, detected by clinical observation, optical coherence tomography (OCT) or retinal fundus photography, at 12 months (with an acceptable follow‐up range of between six and 18 months); </p> </li> <li> <p>effect on distance BCVA, measured in logMAR and considered as a dichotomous outcome (being the proportion of eyes that experienced a loss of 15 or more letters from baseline BCVA), at six months (with an acceptable follow‐up range of three to nine months); </p> </li> <li> <p>effect on contrast sensitivity function, measured in log Contrast Sensitivity (%), and considered as a continuous outcome using the mid‐range of the available spatial frequencies (between six and 12 cycles per degree), under photopic conditions, as determined by various contrast acuity charts, at six months (with an acceptable follow‐up range of three to nine months); </p> </li> <li> <p>effect on colour discrimination, measured as the proportion of eyes that had a measurable loss of colour discrimination from baseline using the Farnsworth‐Munsell 100‐hue colour test score under photopic conditions, at six months (with an acceptable follow‐up range of three to nine months); </p> </li> <li> <p>effect on average retinal macular pigment optical density (MPOD), measured as the proportion of eyes that had a significant increase in MPOD at six months (with an acceptable follow‐up range of three to nine months); </p> </li> <li> <p>effect on daytime alertness, considered as the proportion of participants who had reduced daytime alertness when measured using the Epworth Sleepiness Scores, at six months (with an acceptable follow‐up range of three to nine months); </p> </li> <li> <p>effect on reaction time, as a cognitive outcome variable, considered as the proportion of participants who had reduced reaction times, at six months (with an acceptable follow‐up range of three to nine months); </p> </li> <li> <p>proportion of people who were overall satisfied with their visual outcome at six months (with an acceptable follow‐up range of three to nine months). </p> </li> </ul> </p> <section id="CD011977-sec-0051"> <h6 class="title">Adverse effects</h6> <p>We tabulated findings relating to ocular and systemic adverse effects, as reported in the included studies. </p> </section> </section> </section> </section> <section id="CD011977-sec-0052"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011977-sec-0053"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Eyes and Vision Information Specialist conducted systematic searches in the following databases for RCTs. There were no language or publication year restrictions. The date of the search was 25 October 2017. </p> <p> <ul id="CD011977-list-0002"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 9) (which contains the Cochrane Eyes and Vision Trials Register) in the Cochrane Library (searched 25 October 2017) (<a href="./appendices#CD011977-sec-0116">Appendix 1</a>); </p> </li> <li> <p>MEDLINE Ovid (1946 to 25 October 2017) (<a href="./appendices#CD011977-sec-0117">Appendix 2</a>); </p> </li> <li> <p>Embase Ovid (1980 to 25 October 2017) (<a href="./appendices#CD011977-sec-0118">Appendix 3</a>); </p> </li> <li> <p>LILACS (1982 to 25 October 2017) (<a href="./appendices#CD011977-sec-0119">Appendix 4</a>); </p> </li> <li> <p>ISRCTN registry (<a href="http://www.isrctn.com/editAdvancedSearch" target="_blank">www.isrctn.com/editAdvancedSearch</a>; searched 25 October 2017) (<a href="./appendices#CD011977-sec-0120">Appendix 5</a>); </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 25 October 2017) (<a href="./appendices#CD011977-sec-0121">Appendix 6</a>); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 25 October 2017) (<a href="./appendices#CD011977-sec-0122">Appendix 7</a>). </p> </li> </ul> </p> </section> <section id="CD011977-sec-0054"> <h4 class="title">Searching other resources</h4> <p>We undertook additional searching using the bibliographies of included RCTs to identify other potentially relevant studies. We did not handsearch conference abstracts for this review, as Cochrane Eyes and Vision routinely conducts handsearching for RCTs from major ophthalmology meetings and incorporates these results into CENTRAL. </p> </section> </section> <section id="CD011977-sec-0055"> <h3 class="title" id="CD011977-sec-0055">Data collection and analysis</h3> <section id="CD011977-sec-0056"> <h4 class="title">Selection of studies</h4> <p>We adopted a two‐stage process to select studies for this review.</p> <p>First, two of the review authors (LED, PRK) independently evaluated the title and abstract results from the electronic search strategies, in order to identify potentially suitable studies for inclusion in the review. </p> <p>Next, we obtained full‐text copies for studies that at least one review author deemed relevant or possibly relevant to the review. Two review authors (LED, PRK) independently assessed each full‐text article and classified its suitability for inclusion in the review, according to the <a href="#CD011977-sec-0044">Criteria for considering studies for this review</a> into one of three categories: (i) definitely include, (ii) inclusion status unclear or (iii) definitely exclude. </p> <p>We resolved discrepancies in classification by discussion to reach consensus between the two review authors. For cases where we considered further information was necessary to determine the eligibility of a study for inclusion, we contacted the study authors for this information. If we did not receive a response from the study authors within four weeks of initial contact, or they did not provide the requested information, we used the information within the full‐text article to decide upon the eligibility of the study. We have provided details relating to the reason for excluding studies that underwent full‐text review in the ‘<a href="./references#CD011977-sec-0132" title="">Characteristics of excluded studies</a>’ table. </p> </section> <section id="CD011977-sec-0057"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (LED, PRK) independently extracted key study data (detailed in <a href="./appendices#CD011977-sec-0123">Appendix 8</a>) using Covidence (<a href="./references#CD011977-bbs2-0100" title="Veritas Health Innovation. Covidence. Melbourne, Australia: Veritas Health Innovation, accessed 19 September 2017. ">Covidence</a>). We collected details relating to the study design, participant characteristics, number of participants, outcomes, results and any other relevant information (e.g. funding sources). Wherever possible, we extracted quantitative data for outcomes. We resolved any discrepancies in data extraction by discussion to reach consensus; adjudication by the third review author was not required. After reaching consensus in Covidence, one review author (LED) exported collated data into Cochrane's Review Manager 5 (RevMan 5) software (<a href="./references#CD011977-bbs2-0137" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and a second review author (LB) independently verified the data. </p> </section> <section id="CD011977-sec-0058"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LED, PRK) independently assessed the risk of bias in each of the included studies using the guidelines in Chapter 8 of the <i>Cochrane Handbook for Systematic Review of Interventions</i> (<a href="./references#CD011977-bbs2-0113" title="HigginsJP , AltmanDG , Sterne JACeditor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). We evaluated the risk of bias in the following domains: </p> <p> <ul id="CD011977-list-0003"> <li> <p>selection bias (random sequence generation and allocation concealment);</p> </li> <li> <p>performance bias (masking of participants and personnel);</p> </li> <li> <p>detection bias (masking of outcome assessment);</p> </li> <li> <p>attrition bias (incomplete outcome data);</p> </li> <li> <p>reporting bias (selective reporting of outcomes);</p> </li> <li> <p>other bias (funding source, other conflicts of interest).</p> </li> </ul> </p> <p>Each review author made a judgement regarding the estimated risk of each type of bias in each included study as: (i) low risk, (ii) unclear risk (due to either lack of information or uncertainty over the potential for bias) or (iii) high risk. The review authors (LED, PRK) resolved disagreements in bias assessment by consensus. </p> </section> <section id="CD011977-sec-0059"> <h4 class="title">Measures of treatment effect</h4> <p>We undertook the data analyses according to the methods described in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011977-bbs2-0101" title="DeeksJJ , HigginsJP , Altman DGeditor(s) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> <p>For continuous outcomes, we extracted information on the change in means of the outcome measures for the intervention and comparator groups at the specified follow‐up periods and standard deviations of change. Where no change scores were reported, we extracted information on means and standard deviation of the outcome for the intervention and comparator groups at the specified follow‐up periods. We have expressed treatment effects as mean difference (MD) with 95% confidence intervals (CIs) between the intervention and comparator groups. </p> <p>For dichotomous outcomes (including progression to late‐stage AMD and development of early stages of AMD), we compared the proportion of eyes reaching defined categories of AMD (i.e., any AMD or late‐stage AMD) between the intervention and control groups at the nominated time points. We have presented treatment effects as risk ratios (RRs) with 95% CIs. </p> </section> <section id="CD011977-sec-0060"> <h4 class="title">Unit of analysis issues</h4> <p>For the purpose of this review, the unit of analysis was the enrolled study eye of the participant. Where the study collected data on more than one eye per participant, we followed guidelines for clustering or paired‐eye design described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011977-bbs2-0114" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). </p> <p>Some trials randomised one or both eyes to the intervention or comparator. When participants were randomly allocated to treatment but only one eye per person was included in the trial, then there was no unit of analysis issue. When participants were randomly allocated to treatment and both eyes per person were included, and the average value of both eyes was reported, then there was no unit of analysis issue. When participants were randomly allocated to treatment but both eyes were included and reported separately, we indicated in our protocol that we would analyse this as 'clustered data' (i.e., adjusted for within‐person correlation). In our protocol we had also stated that if the study was a within‐person study (i.e., one eye was randomly allocated to the intervention and the other eye received the comparator intervention), then we would analyse this as 'paired data'. </p> <p>There were some studies that had data relevant to the review outcomes where both eyes were included in the study (i.e., a paired‐eye trial), but the data were reported as independent observations (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>). For these trials, we attempted to contact the study authors via email to obtain information to perform a matched analysis, but either did not receive a response within four weeks of our request, or received an automated alert that the email address no longer existed. In two studies, more than one eye from an individual participant was included in the analysis but details of the intra‐class correlation coefficient for within‐person clustering were not provided (<a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>). For each of these studies, we attempted to contact the study authors via email to obtain the necessary information, but either did not receive a response within four weeks of our request, or received an automated alert that the email address no longer existed. </p> </section> <section id="CD011977-sec-0061"> <h4 class="title">Dealing with missing data</h4> <p>For any studies where we identified missing outcome data (e.g., omitted standard deviations, standard errors), we attempted to contact the study authors (see <a href="./references#CD011977-sec-0131" title="">Characteristics of included studies</a> for further details). If we did not receive a response from them within four weeks, or if they were unable to provide this further information, we used the information that was available within the publication. </p> <p>We had specified in our protocol that if an intention‐to‐treat (ITT) analysis was provided, we would use these data in our analyses. As none of the included studies reported undertaking an ITT analysis, we analysed the data reported by the study authors. </p> </section> <section id="CD011977-sec-0062"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed studies for heterogeneity using the recommendations outlined in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011977-bbs2-0101" title="DeeksJJ , HigginsJP , Altman DGeditor(s) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> <p>We assessed for clinical and methodological heterogeneity between studies by examining differences in trial design, participant characteristics at baseline (e.g., age, gender, eligibility criteria, etc.) and risk of bias. We quantified statistical heterogeneity between studies using the I<sup>2</sup> statistic (<a href="./references#CD011977-bbs2-0112" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). We interpreted an I<sup>2</sup> statistic of 60% or more to be at risk of moderate heterogeneity (<a href="./references#CD011977-bbs2-0131" title="NgSM , LindsleyK , AkpekEK . Omega‐3 and omega‐6 polyunsaturated fatty acids for dry eye syndrome. Cochrane Database of Systematic Reviews2014, Issue 3. [DOI: 10.1002/14651858.CD011016] ">Ng 2014</a>). In identifying and measuring heterogeneity, we also examined the magnitude and direction of effects of individual studies as well as the strength of evidence for heterogeneity (using a P value &lt; 0.10, from the Chi<sup>2</sup> test) as an indication of significant heterogeneity. </p> </section> <section id="CD011977-sec-0063"> <h4 class="title">Assessment of reporting biases</h4> <p>We had intended to assess the risk of reporting bias (due to selective reporting of outcomes) by comparing the outcomes defined in the trial protocol with those in the publication(s). However, none of the included trials had published protocols or methodological papers. There were two trials that had been prospectively registered in a clinical trials registry; for these studies, we compared study outcomes in the publication with the trial registry entry. </p> <p>As we included fewer than 10 studies in any of the meta‐analyses, we were not able to assess for the potential effect of publication bias. </p> </section> <section id="CD011977-sec-0064"> <h4 class="title">Data synthesis</h4> <p>Where studies were multi‐arm studies that randomly assigned participants to more than one type of IOL, we considered data from the relevant study arms in the analyses by calculating the relevant point estimate and measure of variability for each main category of IOL (i.e., non‐blue light filtering and blue‐light filtering). We considered the intervention groups of relevance to be all those that could be included in a pair‐wise comparison of intervention groups that, if investigated alone, would meet the criteria for including studies in the review. </p> <p>Where appropriate, we performed a meta‐analysis for primary or secondary outcomes, or both. When we included fewer than three RCTs in a meta‐analysis, we used a fixed‐effect model. When we included three or more RCTs in a meta‐analysis, we used a random‐effects model. </p> <p>As there was adequate consistency between individual study results for a pooled result to provide a good summary of the trial findings (i.e. effects in the same directions, I<sup>2</sup> &lt; 60%, or a Chi<sup>2</sup> test P value &gt; 0.10), we pooled data. </p> <p>For adverse events, including intraoperative and postoperative complications, we generated tabulated results summaries. </p> </section> <section id="CD011977-sec-0065"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not perform any subgroup analyses for prognostic factors (i.e., gender and age) at baseline for the primary outcome measure, as there was not a sufficient number of studies (considered two studies per subgroup or more) to perform these analyses. </p> </section> <section id="CD011977-sec-0066"> <h4 class="title">Sensitivity analysis</h4> <p>We had planned to perform a sensitivity analysis on the primary outcome measure, to assess the effect of excluding studies that: (i) had a high risk of bias (due to lack of allocation concealment or incomplete outcome data or lack of masking), (ii) were unpublished and (iii) were industry‐funded. We were not able to perform a sensitivity analysis on the primary outcome measure as there were too few studies to permit this analysis. </p> <section id="CD011977-sec-0067"> <h5 class="title">Summary of findings</h5> <p>We prepared a ‘Summary of findings’ table for each comparison to summarise the results of our analyses, using the formats described in Chapter 11 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011977-bbs2-0141" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011</a>). We followed the GRADE Working Group approach to grade the certainty of evidence. Outcomes include: </p> <p> <ul id="CD011977-list-0004"> <li> <p>mean change in number of letters of distance BCVA from baseline BCVA in intervention and control groups after 12 months of follow‐up; </p> </li> <li> <p>proportion of participants who lost 15 or more letters of distance BCVA from baseline BCVA in intervention and control groups after six months of follow‐up; </p> </li> <li> <p>mean change in contrast sensitivity from baseline in intervention and control groups after six months of follow‐up; </p> </li> <li> <p>proportion of eyes with a measurable loss of colour discrimination from baseline in intervention and control groups after six months of follow‐up; </p> </li> <li> <p>proportion of eyes that developed late‐stage AMD in intervention and control groups after three years of follow‐up; </p> </li> <li> <p>proportion of eyes that developed any AMD in intervention and control groups after one year of follow‐up; </p> </li> <li> <p>proportion of participants with adverse events with a probable causal link with the study intervention after six months of follow‐up. </p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011977-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011977-sec-0068"></div> <section id="CD011977-sec-0069"> <h3 class="title">Description of studies</h3> <section id="CD011977-sec-0070"> <h4 class="title">Results of the search</h4> <p>The electronic searches yielded a total of 834 references (<a href="#CD011977-fig-0001">Figure 1</a>). The Cochrane Information Specialist removed 251 duplicate records and we screened the remaining 583 reports for potential inclusion in the review. We obtained 88 full‐text reports or conference abstracts that appeared to meet the pre‐defined inclusion criteria, based upon the abstract screening process. We considered a total of 52 reports of 51 studies to be suitable for inclusion in the review and these are summarised in the <a href="./references#CD011977-sec-0131" title="">Characteristics of included studies</a>. We excluded 32 reports of 32 studies; see <a href="./references#CD011977-sec-0132" title="">Characteristics of excluded studies</a> for details. We categorised one study as ongoing, see <a href="./references#CD011977-sec-0134" title="">Characteristics of ongoing studies</a>, and three studies are still currently awaiting categorisation: <a href="./references#CD011977-bbs2-0084" title="JiHL , XiaoW , PuW . Mesopic visual quality after three kinds of aspheric acrylic monofocal intraocular lenses. International Eye Science2013;13(8):1609‐12. ">Ji 2013</a> is pending translation to English and currently we are unable to source two Chinese papers (<a href="./references#CD011977-bbs2-0085" title="LiHW , GuoHK , ZhangHY , JinHY , ChenYL , LiuMY . Comparative analysis of visual quality after aspheric intraocular lens implantation. International Journal of Ophthalmology2009;9(11):2092‐6. ">Li 2009</a>; <a href="./references#CD011977-bbs2-0086" title="ShiD , ZhangJS . Impact of different intraocular lens design on the wave‐front aberration of pseudophakic eyes. International Journal of Ophthalmology2008;8(1):71‐3. ">Shi 2008</a>). See <a href="./references#CD011977-sec-0133" title="">Characteristics of studies awaiting classification</a> for details. </p> <div class="figure" id="CD011977-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD011977-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD011977-sec-0071"> <h4 class="title">Included studies</h4> <section id="CD011977-sec-0072"> <h5 class="title">Types of studies</h5> <p>Of the 51 included studies, 12 consisted of conference abstracts and 39 were full‐text articles. The individual study designs differed across the included studies, and involved: </p> <p> <ul id="CD011977-list-0005"> <li> <p>the unit of randomisation being the participant, with bilateral implantation of a randomly allocated IOL type (i.e. blue‐light filtering or non‐blue‐light filtering), where the unit of analysis for inter‐group comparisons was the study eye (<a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>), the average of both eyes (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>), both eyes without apparent statistical adjustment (<a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>), or was unclear (<a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a>; <a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a>). One study, involving bilateral IOL implantation only reported non‐ocular outcomes, and thus the unit of analysis was the participant (<a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a>). For the study where one eye was included in the analysis (<a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>), the method of selection was the dominant eye, although it was not stated whether this was a pre‐planned or post hoc selection. </p> </li> <li> <p>the unit of randomisation being the participants, unilateral implantation of a randomly allocated IOL type with inter‐group comparisons (<a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>; <a href="./references#CD011977-bbs2-0044" title="UedaT , OtaT , YukawaE , HaraY . Frequency doubling technology perimetry after clear and yellow intraocular lens implantation. American Journal of Ophthalmology2006;142(5):856‐8. ">Ueda 2006</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a>); </p> </li> <li> <p>a paired‐eye design, whereby one eye randomly received a blue‐light filtering IOL and the fellow eye received a non‐blue‐light filtering IOL for intra‐individual comparisons (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>; <a href="./references#CD011977-bbs2-0019" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue filter: SN 60/SA 60, HOYA‐YA/HOYA‐VA on the F.A.C.T. test facility. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 1):S8. ">Hahsler 2005</a>; <a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>); </p> </li> <li> <p>a combination of bilateral and unilateral IOL implantations, where one eye per individual was used for inter‐group comparisons (<a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>) or no further information was provided regarding the unit of analysis (<a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0021" title="HyunseokA , KimSW , KimEK , LeeAY , KimT . Comparison of an aspherical IOL with a spherical IOU wavefront analysis and visual quality. American Academy of Ophthalmology. 2007:210. ">Hyunseok 2007</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>). </p> </li> </ul> </p> <p>Additionally, in a number of studies, there was lack of a clear description relating to whether IOL allocation was bilateral or unilateral (<a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a>; <a href="./references#CD011977-bbs2-0004" title="Behrens‐BaumannW , WalterS , MullerS , KuchenbeckerJ , LindnerH . Comparison of two lOLs: Hoya AF‐ I (UV) VA6013B vs. AF‐1 (UY) YA‐60BB. American Academy of Ophthalmology. 2005:185. ">Behrens‐Baumann 2005</a>; <a href="./references#CD011977-bbs2-0006" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of neutral and blue‐blocking intraocular lenses on circadian photoentrainment. Investigative Ophthalmology and Visual Science2014; Vol. 55, issue 13:4184. ">Brøndsted 2014</a>; <a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0018" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue light filter: a comparison of SN60 and SA60. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 1):S15‐6. ">Hahsler 2004</a>; <a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a>; <a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>; <a href="./references#CD011977-bbs2-0036" title="RochaKM , NoseW , ChalitaM , YamadaAN , MorimotoL , BottosK , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: a randomized prospective study. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 1502. ">Rocha 2006a</a>; <a href="./references#CD011977-bbs2-0037" title="RochaKM , NoseW , ChalitaMR , YamadaAC , BottosK , BottosJ , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: randomized prospective study. American Academy of Ophthalmology. 2006:200. ">Rocha 2006b</a>; <a href="./references#CD011977-bbs2-0042" title="SorianoES , RochaKM , NoseW , MonmotoM , ChalitaMR , ChamonW . Correlation between near vision and pupil size in aspheric and spherical IOLs. American Academy of Ophthalmology. 2006:209. ">Soriano 2006</a>; <a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a>; <a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a>; <a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>). </p> <p>For studies where one eye was randomised to one intervention group and the fellow eye was randomised to another intervention group, we noted that the analyses reported in these studies did not describe taking into account the non‐independence of eyes by using paired‐eye analysis methods. For most studies where bilateral IOL implantation was performed, data were inappropriately analysed as independent observations, without taking into account the relative non‐independence of eyes. In an attempt to incorporate studies adopting clustered or paired designs in our meta‐analyses, wherever possible, we contacted the authors of studies to obtain relevant data relating to within‐person differences or within‐person clustering for our prespecified outcome measures. </p> </section> <section id="CD011977-sec-0073"> <h5 class="title">Types of participants</h5> <p>We included 51 RCTs in which the participants were adults (i.e. at least 18 years of age), where a blue‐light filtering IOL was compared with an equivalent type of non‐blue‐light filtering IOL. Together, these studies considered the outcomes of IOL implantation in over 5000 eyes. Based upon data reported in the studies, the number of participants in each trial ranged from 13 to 300. The follow‐up period of the studies ranged from one month to five years after cataract surgery. </p> <p>The studies were conducted in 17 different countries: one in Australia (<a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>), six in Austria (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0018" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue light filter: a comparison of SN60 and SA60. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 1):S15‐6. ">Hahsler 2004</a>; <a href="./references#CD011977-bbs2-0019" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue filter: SN 60/SA 60, HOYA‐YA/HOYA‐VA on the F.A.C.T. test facility. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 1):S8. ">Hahsler 2005</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>), one in Belgium or Switzerland (unclear) (<a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>), four in Brazil (<a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a>), three in China (<a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a>), one in Croatia (<a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>), three in Denmark (<a href="./references#CD011977-bbs2-0006" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of neutral and blue‐blocking intraocular lenses on circadian photoentrainment. Investigative Ophthalmology and Visual Science2014; Vol. 55, issue 13:4184. ">Brøndsted 2014</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a>), one in England (<a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>), one in Finland (<a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>), one in France (<a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>), four in Germany (<a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a>), four in India (<a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a>; <a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>), one in Ireland (<a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>), two in Italy (<a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>), five in Japan (<a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0044" title="UedaT , OtaT , YukawaE , HaraY . Frequency doubling technology perimetry after clear and yellow intraocular lens implantation. American Journal of Ophthalmology2006;142(5):856‐8. ">Ueda 2006</a>; <a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a>; <a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>), two in Korea (<a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>), one in Scotland (<a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>) and two in the USA (<a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>). Investigators of eight studies did not report in which country the trial had been conducted (<a href="./references#CD011977-bbs2-0004" title="Behrens‐BaumannW , WalterS , MullerS , KuchenbeckerJ , LindnerH . Comparison of two lOLs: Hoya AF‐ I (UV) VA6013B vs. AF‐1 (UY) YA‐60BB. American Academy of Ophthalmology. 2005:185. ">Behrens‐Baumann 2005</a>; <a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a>; <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>; <a href="./references#CD011977-bbs2-0021" title="HyunseokA , KimSW , KimEK , LeeAY , KimT . Comparison of an aspherical IOL with a spherical IOU wavefront analysis and visual quality. American Academy of Ophthalmology. 2007:210. ">Hyunseok 2007</a>; <a href="./references#CD011977-bbs2-0036" title="RochaKM , NoseW , ChalitaM , YamadaAN , MorimotoL , BottosK , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: a randomized prospective study. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 1502. ">Rocha 2006a</a>; <a href="./references#CD011977-bbs2-0037" title="RochaKM , NoseW , ChalitaMR , YamadaAC , BottosK , BottosJ , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: randomized prospective study. American Academy of Ophthalmology. 2006:200. ">Rocha 2006b</a>; <a href="./references#CD011977-bbs2-0042" title="SorianoES , RochaKM , NoseW , MonmotoM , ChalitaMR , ChamonW . Correlation between near vision and pupil size in aspheric and spherical IOLs. American Academy of Ophthalmology. 2006:209. ">Soriano 2006</a>; <a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a>). </p> <p>For all trials, an inclusion criterion was a clinical indication for cataract surgery. In one study (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>), participants had a diagnosis of vitreoretinal pathology, including diabetic vitreous haemorrhage, macular hole, epiretinal membrane or persisting macula oedema, with coexisting significant cataract. One trial (<a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>), described a group of 'control' participants not undergoing cataract surgery; we did not include data from these participants in our analyses. In one trial, all participants were moderate red–green anomalous trichromats (<a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>). </p> <p>Several studies excluded participants with intraoperative complications (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>; <a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a>; <a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>), postoperative complications (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a>; <a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>), incomplete follow‐up (<a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>) and/or reduced actual (<a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>) or anticipated (<a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>) postoperative visual acuity. Some trials indicated that no participants developed intraoperative or postoperative complications (<a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a>) but most studies did not report on how many participants were excluded due to such effects, which may have affected our ability to report upon all potential adverse events from the interventions. </p> </section> <section id="CD011977-sec-0074"> <h5 class="title">Types of interventions</h5> <p>All included trials compared at least one blue‐light filtering IOL to at least one non‐blue‐light filtering IOL. In one study, all participants underwent phacoemulsification and IOL implantation, followed by a vitreo‐retinal procedure (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>). </p> <p><a href="#CD011977-tbl-0002">Table 1</a> summarises the specific IOLs used in each trial. Most studies used one type of blue‐light filtering IOL and compared this directly with a non‐blue‐light filtering IOL, although some studies considered multiple IOL types. One trial did not report the IOLs investigated in the study (<a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a>). </p> <div class="table" id="CD011977-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Details of the intraocular lenses (IOLs) used as interventions in each study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Blue‐light filtering IOL name(s)<sup>a</sup> (Manufacturer)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Non‐blue‐light filtering IOL name(s)<sup>a</sup><br/> (Manufacturer)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon) or AcrySof MA60BM (Alcon) or VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or PC4406 (Optech)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof MA60BM (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0004" title="Behrens‐BaumannW , WalterS , MullerS , KuchenbeckerJ , LindnerH . Comparison of two lOLs: Hoya AF‐ I (UV) VA6013B vs. AF‐1 (UY) YA‐60BB. American Academy of Ophthalmology. 2005:185. ">Behrens‐Baumann 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0006" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of neutral and blue‐blocking intraocular lenses on circadian photoentrainment. Investigative Ophthalmology and Visual Science2014; Vol. 55, issue 13:4184. ">Brøndsted 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AMO ZCBOO (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AMO ZCBOO (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar AR40e (Abbott Medical Optics) or Tecnis Z9000 (Abbott Medical Optics) or Sofport L161AO (Bausch &amp; Lomb) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar AR40e (Abbott Medical Optics) or Tecnis Z9000 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SB30AL (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA30AL (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9001 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9000 (Abbott Medical Optics) or Cee On Edge (Abbott Medical Optics) or Akreos AO (Bausch &amp; Lomb) or Akreos Adapt (Bausch &amp; Lomb) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof single‐piece (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Akreos Fit (Bausch &amp; Lomb) or Akreos AO (Bausch &amp; Lomb) or AcrySof SA60AT as described in the methods (but appears to be inadvertently described as the MA60AC in the reporting of the results) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural (Alcon) or AF‐1 UY (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof single‐piece (Alcon) or AF‐1 UV (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0018" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue light filter: a comparison of SN60 and SA60. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 1):S15‐6. ">Hahsler 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SN60 (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SA60 (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0019" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue filter: SN 60/SA 60, HOYA‐YA/HOYA‐VA on the F.A.C.T. test facility. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 1):S8. ">Hahsler 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA (Hoya) or SN60 (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA (Hoya) or SA60 (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0021" title="HyunseokA , KimSW , KimEK , LeeAY , KimT . Comparison of an aspherical IOL with a spherical IOU wavefront analysis and visual quality. American Academy of Ophthalmology. 2007:210. ">Hyunseok 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis ZA9003 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof MA30AC (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9000 (Pfizer) or Opti‐Edge (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OII Biovue3 (BioVue) or YA60BBR (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9003 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof single‐piece SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural IOL SB30AL (Alcon) (the current marketed version of this lens is the SN60AT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA30AL (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UY (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UV (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof MA60AC (Alcon) or AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF1 UY (Hoya) or AcrySof SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF1 UV (Hoya) or AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60AT (Alcon) or AcrySof SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0036" title="RochaKM , NoseW , ChalitaM , YamadaAN , MorimotoL , BottosK , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: a randomized prospective study. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 1502. ">Rocha 2006a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ (Alcon) or AcrySof Natural (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0037" title="RochaKM , NoseW , ChalitaMR , YamadaAC , BottosK , BottosJ , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: randomized prospective study. American Academy of Ophthalmology. 2006:200. ">Rocha 2006b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ (Alcon) or AcrySof Natural (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ (Alcon) or AcrySof SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar AR40 (Allergan)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oculaid PC 440Y Orange Series (Ophtec BV)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oculaid PC 430Y Elite Series (Ophtec BV)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UY (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UV (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis ZCB (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0042" title="SorianoES , RochaKM , NoseW , MonmotoM , ChalitaMR , ChamonW . Correlation between near vision and pupil size in aspheric and spherical IOLs. American Academy of Ophthalmology. 2006:209. ">Soriano 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60AT (Alcon) or AcrySof SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ENV‐13 (Menicon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ES‐13 (Menicon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0044" title="UedaT , OtaT , YukawaE , HaraY . Frequency doubling technology perimetry after clear and yellow intraocular lens implantation. American Journal of Ophthalmology2006;142(5):856‐8. ">Ueda 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UV‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AY‐1 UY (Hoya) or Arium Matrix Model 4000 (Medennium)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MC611MI (HumanOptics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60WF (Alcon) or AcrySof SN60AT (Alcon) or Py60AD (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9003 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60WF (Alcon) or AcrySof SN60AT (Alcon) or Py60AD (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9003 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported (not reported)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Details of the interventions are provided as per the details available in the included studies. <br/> <sup>b</sup><a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>, reported two‐year follow‐up data for four out of five of the intervention groups from the <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a> study (data from the Sofport L161AO group were not provided, although no explanation was provided). </p> </div> </div> </section> <section id="CD011977-sec-0075"> <h5 class="title">Primary outcome</h5> <p>As a frequent measure of visual function, distance best‐corrected visual acuity (BCVA) was reported, in various forms and in varying degrees of detail, in many of the included studies. </p> <p>Six studies (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>) presented data that we judged to be potentially relevant to the primary outcome, defined as the change in distance BCVA, and considered as a continuous variable. The methods adopted to assess BCVA involved quantification on an Early Treatment of Diabetic Retinopathy Study (ETDRS) chart under photopic conditions (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>), Snellen chart under photopic conditions (<a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>), or was not reported (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>). </p> <p>In our protocol, we prespecified that we would obtain data between baseline and 12 months of follow‐up for this outcome measure, but that we would accept measures between six and 18 months of follow‐up, and that if studies did not report the change in distance BCVA, we would utilise data reported at the end of the follow‐up period. The trial designs of the six studies were single‐eye comparisons (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>), paired‐eye comparisons (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>) and a clustered design including where data from more than one eye of some participants were included (<a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>). We attempted to contact the authors of studies utilising paired‐eye and clustered designs, to obtain relevant information relating to within‐person clustering or within‐person differences, or both, to be able to include these data in a meta‐analysis. Each of the six studies reported BCVA data at the end of the follow‐up period, rather than the change from baseline. For one study (<a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>), the unit of measure for distance BCVA was not defined in the paper; for all other studies, the unit of measure was in LogMAR. </p> <p>Several studies reported data relating to distance BCVA that were not directly relevant to the primary outcome, due to: </p> <p> <ul id="CD011977-list-0006"> <li> <p>the postoperative follow‐up period being less than six months (<a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a>; <a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>; <a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>; <a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0044" title="UedaT , OtaT , YukawaE , HaraY . Frequency doubling technology perimetry after clear and yellow intraocular lens implantation. American Journal of Ophthalmology2006;142(5):856‐8. ">Ueda 2006</a>; <a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>); </p> </li> <li> <p>the postoperative follow‐up period being in excess of 18 months (<a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>: 24 months); </p> </li> <li> <p>data being presented in an alternative format:</p> <ul id="CD011977-list-0007"> <li> <p><a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>: reported distance BCVA as a 'visual acuity rating' (VAR) at 12 months after surgery, which could not be incorporated in our statistical analysis of this outcome. In this study, it was reported that "similar improvements in acuity were observed in (both intervention groups) over the time course of the study"; </p> </li> <li> <p><a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>: measured distance BCVA categorically as the number of eyes with BCVA of 0.8, 0.9 or 1.0 decimal acuity after six months of follow‐up, which could not be included in the statistical analysis; </p> </li> </ul> </li> <li> <p>a lack of quantitative data within the publication (<a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a>; <a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a>; <a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>). </p> </li> </ul> </p> </section> <section id="CD011977-sec-0076"> <h5 class="title">Secondary outcomes</h5> <section id="CD011977-sec-0077"> <h6 class="title">Proportion of eyes with late‐stage AMD (neovascular AMD or geographic atrophy)</h6> <p>One trial (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>) reported data relevant to the proportion of eyes with late‐stage AMD (being neovascular AMD or geographic atrophy) at three‐years of follow‐up (with an acceptable follow‐up range of between two and four years). </p> </section> <section id="CD011977-sec-0078"> <h6 class="title">Proportion of eyes with any stage of AMD</h6> <p>For the outcome involving the proportion of eyes with any stage of AMD, as defined by the study investigators at 12 months (with an acceptable follow‐up range of between six and 18 months), there were two relevant studies (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>). <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a> examined macular findings, determined by optical coherence tomography (OCT) analysis and retinal examination by a masked retinal specialist, at five years of follow‐up and reported "no significant clinical or OCT findings with respect to AMD in any case", in the 25 individuals participating in this paired‐eye trial. The OCT used in this study was a Stratus OCT, with central retinal thickness quantified using the Stratus OCT Reading Software (version 4.1, Carl Zeiss Meditec, Incorporated). In <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>, also a paired‐eye trial, where participants were followed up for 12 months postoperatively, it was reported that "there were no pathologic findings on fundus examination in any eye at any follow‐up visit." As there were no eyes that developed AMD, of any stage, in any of the intervention groups, in either of the studies, meta‐analysis was not possible for this outcome. </p> </section> <section id="CD011977-sec-0079"> <h6 class="title">Proportion of eyes with structural macular change</h6> <p>Four studies (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a>) presented data that were considered potentially relevant to the outcome relating to the proportion of eyes with a finding of a pathological structural change at the macula, as detected by clinical observation, OCT or retinal fundus photography at 12 months (with an acceptable follow‐up range of between six and 18 months). </p> <p>In the <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a> study, it was reported that "one patient (in the blue‐light filtering IOL group) had a cystoid macular oedema at nine months after surgery." In the <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a> study, the same IOLs were bilaterally implanted; the relative non‐independence of eyes from a given participant did not appear to be factored into the statistical analysis. In this trial, it was reported that at six months of follow‐up, six eyes in the blue‐light filtering IOL group had developed cystoid macula oedema and six eyes required secondary surgical intervention; none of the occurrences were considered IOL‐related. In addition, in the non‐blue‐light filtering IOL group, three eyes developed cystoid macula oedema and three eyes required secondary surgical intervention; none of the occurrences were considered IOL‐related.In the paired‐eye <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a> trial, no pathological findings were identified in the blue‐light filtering or non‐blue‐light filtering IOL groups. For the <a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a> study, being an Association for Research in Vision and Ophthalmology (ARVO) conference abstract, the number of eyes assigned to each treatment group, from the 31 participants recruited, was not provided; we attempted to contact the study authors for this information, but were not successful; data from this study could thus not be included in the review for this outcome. In the conference abstract, the authors reported that in the blue‐light filtering IOL group, cystoid macular oedema was evident in 25% of participants at three months of follow‐up, and 9% of participants at 12 months of follow‐up. In the non‐blue‐light filtering IOL group, it was reported that cystoid macular oedema was present in 28% of participants at three months of follow‐up, and 17% of participants at 12 months of follow‐up. The type of OCT used in the study was not reported. </p> </section> <section id="CD011977-sec-0080"> <h6 class="title">Effect on distance BCVA (logMAR)</h6> <p>For the effect on distance BCVA, measured in logMAR and considered as a dichotomous outcome (being the proportion of eyes that experienced loss of 15 or more letters from baseline BCVA) at six months postoperatively (with an acceptable follow‐up range of three to nine months), there were two studies reporting relevant data (<a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>). Neither of these studies excluded participants on the basis of intraoperative and/or postoperative complications. In both studies, there were no cases of a loss of distance BCVA in either intervention group; as such, a meta‐analysis was not feasible for this secondary outcome. </p> </section> <section id="CD011977-sec-0081"> <h6 class="title">Contrast sensitivity</h6> <p>In relation to effects on contrast sensitivity, many of the included studies reported data, in various forms and with varying degrees of detail. Nine studies (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a>) presented data that we considered potentially relevant to this outcome, defined as the effect on the contrast sensitivity function, measured in log Contrast Threshold (%), and considered as a continuous outcome using the mid‐range of the available spatial frequencies (between six and 12 cycles/degree), under photopic conditions, as determined by various contrast acuity charts, at six months (with an acceptable follow‐up range of three to nine months). Of these potentially relevant trials, five studies (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a>) did not provide details relating to measures of variability for this outcome; we attempted to contact the study authors for this information, but this was not successful, and thus we were unable to include data from these trials. One trial (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>) reported changes to contrast acuity, from baseline, measured using the Pelli Robson chart, quantified in log contrast sensitivity, at three months postsurgery. The trial by <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> reported photopic contrast sensitivity data at six‐months postoperatively (i.e. at the study endpoint) using the Pelli‐Robson chart; although the spatial frequency was not specified, we considered these data relevant to the review and incorporated this information in our analyses. Both the <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a> and <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a> trials were paired‐eye studies, reporting data at 12 cycles/degree after six months of follow‐up; we contacted the authors of both studies to provide information relating to the means and standard deviations of the within‐pair differences in contrast sensitivity at follow‐up, and for P‐values from the repeated measures ANOVA or paired samples t‐tests; however we did not receive this information, and thus could not incorporate data from these trials in a meta‐analysis. </p> </section> <section id="CD011977-sec-0082"> <h6 class="title">Reaction time</h6> <p>One study (<a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>) included a figure (box and whisker plot) that reported data relating to reaction time, as a cognitive outcome variable, at three months of follow‐up. The study authors stated that "Both lenses had an identical mean choice reaction time improvement; Mann–Whitney U testing showed no significant difference in lens effect (P=0.272)." </p> </section> <section id="CD011977-sec-0083"> <h6 class="title">Overall satisfaction</h6> <p>One study (<a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>) reported on the proportion of people who were overall satisfied with their visual outcome after six months. The authors stated that "high patient satisfaction was noticed since 96.7% of patients would implant (the) AcrySof Natural IOL again (Figure 6). Only one patient would not implant this lens again due to the fact that other people could see a yellow »shine« in his eye. Out of six patients having AcrySof Natural IOL in one eye and a standard AcrySof IOL in other eye, three patients were more satisfied with AcrySof Natural IOL, two didn't notice any difference and one was more satisfied with AcrySof MA60BM IOL." </p> <p>There were no relevant extractable data for outcomes relating to the following secondary outcomes. </p> <p> <ul id="CD011977-list-0008"> <li> <p>The effect on colour discrimination, measured as the proportion of eyes that had a measurable loss of colour discrimination from baseline using the Farnsworth‐Munsell 100‐hue colour test score under phototopic conditions, at six months of follow‐up. Several studies considered colour vision, but some only included subjective‐reported outcomes (<a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>), did not provide quantitative data in the required format (<a href="./references#CD011977-bbs2-0004" title="Behrens‐BaumannW , WalterS , MullerS , KuchenbeckerJ , LindnerH . Comparison of two lOLs: Hoya AF‐ I (UV) VA6013B vs. AF‐1 (UY) YA‐60BB. American Academy of Ophthalmology. 2005:185. ">Behrens‐Baumann 2005</a>; <a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a>; <a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>; <a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>), used an alternative test to quantify it (i.e., the Ishihara test (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>) and/or Farnsworth D‐15 test (<a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>)), or quantified it at an alternative time‐point (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>). </p> </li> <li> <p>The effect on average macular pigment optical density (MPOD) measured as the proportion of eyes that had a significant increase in MPOD at six months of follow‐up. One study considered MPOD measures (<a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>). This trial reported that "average MPOD across the retina increased significantly with time (after 3 months) in the ANIOL (blue‐light filtering) group (repeated‐measures, general linear model, P &lt; 0.05), but remained stable in the AIOL (non‐blue‐light filtering) group (repeated‐measures, general linear model, P &gt; 0.05)." Although the authors analysed the within‐group trend for change in MPOD separately for each group, they did not report the change from baseline in MPOD between groups. This outcome should be considered in the context that it is unclear, from the available information about this study, whether this was a pre‐planned or post‐hoc analysis. </p> </li> <li> <p>The effect on daytime alertness, considered as the proportion of participants who had reduced daytime alertness measured using the Epworth Sleepiness Score, at six months of follow‐up. One study, <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>, reported on subjective sleep quality, measured using the Pittsburgh Sleep Quality Index (PSQI). The study authors reported that "subjective sleep quality assessed by the PSQI questionnaire was not affected by the surgery (mixed‐model ANOVA, F<sub>64</sub> = 0.91, P = 0.345) or by IOL type (mixed‐model ANOVA, F<sub>63</sub> = 2.04, P = 0.158) (Table 5). The number of poor sleepers was not affected by surgery (Chi‐square test, X<sup>2</sup> = 0.03, P = 0.856) (Table 5)." <a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a>, also reported on subjective sleep quality, using the PSQI. The study authors reported that subjective sleep quality was improved, as the time of wakefulness after sleep onset had improved by five minutes (95% CI, 1 to 10) for the entire population, while sleep efficiency had increased by two percentage points (95% CI, 0.42 to 3.65) although exclusively, for the participants allocated to blue‐blocking IOLs. However, it should be noted that the results of the "Morningness‐eveningness questionnaire", listed as a secondary outcome measure on the clinicaltrials.gov entry for this study, were not reported. </p> </li> <li> <p>One study (<a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a>) only reported quality‐of‐life outcomes, and did not describe any vision‐related outcomes. </p> </li> </ul> </p> </section> </section> <section id="CD011977-sec-0084"> <h5 class="title">Adverse effects</h5> <p>We have summarised data relating to adverse effects in relation to:</p> <p> <ul id="CD011977-list-0009"> <li> <p>intraoperative complications (<a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a>; <a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>); </p> </li> <li> <p>eyes that required neodymium‐doped yttrium aluminium garnet (Nd:YAG) capsulotomy following cataract surgery (<a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>); and </p> </li> <li> <p>postoperative complications (<a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a>; <a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>;<a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010;</a><a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>). </p> </li> </ul> </p> <p>As summarised in <a href="#CD011977-tbl-0003">Table 2</a>, a total of 16 studies reported on intraoperative complications. Together, these studies considered a total of 1815 eyes (15 RCTs), with overall very few intraoperative complications described with either type of IOL. <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a> described one case of IOL dislocation during surgery with a blue‐light filtering IOL. <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a> reported that two (blue‐light filtering IOLs) were placed with one haptic in the capsular bag and one haptic outside the capsular bag; we excluded outcomes from these two participants from the analyses. </p> <div class="table" id="CD011977-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Adverse effects: intraoperative complications</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study population:</b> </p> <p><b>number of participants (number of eyes)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of intraoperative complication(s)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Details of intraoperative complication(s)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOLs: n = 65 (65); this group combined individuals assigned to 2 different blue‐light filtering IOLs </p> <p>Non‐blue‐light filtering IOL: n = 33 (33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (60)</p> <p>Non‐blue‐light filtering IOL: n = 30 (60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 50 (100); this group combined individuals assigned to 2 different blue‐light filtering IOLs </p> <p>Non‐blue‐light filtering IOL: n = 75 (150); this group combined individuals assigned to 3 different non‐blue‐light filtering IOLs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 39 (41)</p> <p>Non‐blue‐light filtering IOL: n = 18 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall: n = 31 (31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One participant developed endophthalmitis and was removed from the trial, being replaced (after re‐randomisation) by another individual. There was one anterior capsular rim tear and one posterior capsule tear without vitreous loss. No details were provided in relation to which group(s) the adverse events occurred in. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 27 (27)</p> <p>Non‐blue‐light filtering IOL: n = 52 (77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (30)</p> <p>Non‐blue‐light filtering IOL: n = 30 (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = ? (42)</p> <p>Non‐blue‐light filtering IOL: n = ? (26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 23 (23)</p> <p>Non‐blue‐light filtering IOL: n = 16 (16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 9 (9)</p> <p>Non‐blue‐light filtering IOL: n = 10 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 150 (300)</p> <p>Non‐blue‐light filtering IOL: n = 147 (294)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 1</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There was one case of lens dislocation during surgery in the blue‐light filtering IOL group, in a case in which a posterior capsule rupture had occurred during cataract extraction. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 19 (19)</p> <p>Non‐blue‐light filtering IOL: n = 40 (40); this group combined individuals assigned to 2 different non‐blue‐light filtering IOLs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 2</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In the blue‐light filtering IOL lens group "two IOLs were placed with 1 haptic in the capsular bag and 1 haptic outside the capsular bag; these 2 patients were also excluded from the final statistical analysis." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 73 (73); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 36 (36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (30)</p> <p>Non‐blue‐light filtering IOL: n = 30 (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 31 (31)</p> <p>Non‐blue‐light filtering IOL: n = 31 (31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 19 (25)</p> <p>Non‐blue‐light filtering IOL: n = 18 (27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>IOL</b>: intraocular lens </p> </div> </div> <p>As summarised in <a href="#CD011977-tbl-0004">Table 3</a>, the time period for reporting postoperative complications or Nd:YAG capsulotomies, or both, ranged from eight weeks to five years of follow‐up. In total, these trials considered more than 1700 eyes (19 RCTs). The risk ratio (RR) of a postoperative complication in the blue‐light filtering IOL group was RR 2.24 (95% CI 0.93 to 5.38), although there was no probable causal link with the intervention. The most common postoperative complication in both intervention groups was the need for a Nd:YAG capsulotomy. </p> <div class="table" id="CD011977-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Adverse effects: postoperative complications and Nd:YAG capsulotomies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study population: number of participants (number of eyes)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of postoperative complication(s)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Details of postoperative complication(s)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOLs: n = 65 (65); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 33 (33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at four weeks of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (60)</p> <p>Non‐blue‐light filtering IOL: n = 30 (60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 3 eyes</p> <p>Non‐blue‐light filtering IOL: n = 4 eyes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Although the study authors reported that "there were no postoperative complications", n = 3 eyes from the blue‐light filtering IOL group and n = 4 eyes from the non‐blue‐light filtering IOL group required Nd:YAG capsulotomy at six months of follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 38 (38)</p> <p>Non‐blue‐light filtering IOL: n = 35 (35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at six months of follow‐up.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 50 (100); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 75 (150); this group combined individuals assigned to three different non‐blue‐light filtering IOLs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at two months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 50 (100); this group combined individuals assigned to 2 different blue‐light filtering IOLs </p> <p>Non‐blue‐light filtering IOL: n = 50 (100); this group combined individuals assigned to 2 different non‐blue‐light filtering IOLs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 1 for Nd:YAG capsulotomy</p> <p>Non‐blue‐light filtering IOL: n = 1 for Nd:YAG capsulotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This study reports the two‐year follow‐up data for a subset of participants from <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>. The study authors reported that "patients who underwent a capsulotomy before two‐year follow‐up (two patients) were excluded as it was not possible to perform aberrometric analysis. Two Nd:YAG laser capsulotomies were required in two patients who had AcrySof SN60AT IOL (blue‐light filtering IOL) and Tecnis Z9000 IOL (non‐blue‐light filtering IOL) implantation." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 39 (41); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 18 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at two months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 27 (27)</p> <p>Non‐blue‐light filtering IOL: n = 52 (77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none for glaucoma or Nd:YAG capsulotomy</p> <p>Non‐blue‐light filtering IOL: none for glaucoma or Nd:YAG capsulotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The study authors reported that "at two years after surgery, all lenses were well centered and there was no evidence of posterior capsule opacity or glaucoma." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (30)</p> <p>Non‐blue‐light filtering IOL: n = 30 (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 3 eyes</p> <p>Non‐blue‐light filtering IOL: n = 1 eye</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL:</p> <p>n = 1 postoperative iris capture,</p> <p>n = 1 spontaneously reabsorbed vitreous haemorrhage,</p> <p>n = 1 cystoid macular oedema at nine months after surgery</p> <p>Non‐blue‐light filtering IOL: n = 1 postoperative iris capture</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 23 (23)</p> <p>Non‐blue‐light filtering IOL: n = 16 (16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at eight weeks of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 38 (38)</p> <p>Non‐blue‐light filtering IOL: n = 36 (36)</p> <p>(In both groups, data were obtained from both eyes and averaged)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Glare symptoms </p> <p>Blue‐light filtering IOL: n = 3 participants</p> <p>Non‐blue‐light filtering IOL: n = 2 participants</p> <p>Cyanopsia </p> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative complications (as measured by participant report of glare symptoms and cyanopsia) at three months after surgery </p> <p>One participant was reported to have a clinically significant epiretinal membrane in the macula (it is unclear which group the participant belonged to) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (30)</p> <p>Non‐blue‐light filtering IOL: n = 30 (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Three patients required neodymium:YAG laser capsulotomy for posterior capsule opacification," however group allocations were not specified. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three participants (although this was not distinguished by the IOL intervention) at five years of follow‐up </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 23 (23)</p> <p>Non‐blue‐light filtering IOL: n = 16 (16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at eight weeks of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 9 (9)</p> <p>Non‐blue‐light filtering IOL: n = 10 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at six months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 150 (300)</p> <p>Non‐blue‐light filtering IOL: n = 147 (294)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 12</p> <p>Non‐blue‐light filtering IOL: n = 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At six months of follow‐up, in the blue‐light filtering IOL group, six eyes developed cystoid macula oedema and six eyes required secondary surgical intervention; none of the occurrences were considered IOL‐related. </p> <p>At six months of follow‐up, in the non‐blue‐light filtering IOL group, three eyes developed cystoid macula oedema and three eyes required secondary surgical intervention; none of the occurrences were considered IOL‐related. </p> <p>The study authors stated that "no Nd:YAG capsulotomy was performed in the first‐eye subgroup in either the test or control groups throughout the study period." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 19 (19)</p> <p>Non‐blue‐light filtering IOL: n = 40 (40); this group combined individuals assigned to 2 different non‐blue‐light filtering IOLs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at three months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 31 (31)</p> <p>Non‐blue‐light filtering IOL: n = 31 (31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at three months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 80 (80); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 38 (38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at 3 months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 19 (25)</p> <p>Non‐blue‐light filtering IOL: n = 18 (27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The study authors stated that "in the biomicroscopic examination (at one month postoperatively) the posterior capsule appeared clear in all test eyes." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = ? (120); this group combined individuals assigned to 3 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = ? (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported at one month of follow‐up</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>IOL</b>: intraocular lens </p> </div> </div> </section> <section id="CD011977-sec-0085"> <h5 class="title">Funding sources</h5> <p>Thirty‐six of the 51 included studies did not report their source of funding. Four trials (<a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>) were funded by an IOL manufacturer, three trials (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015)</a> received philanthropic funding and eight trials (<a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0036" title="RochaKM , NoseW , ChalitaM , YamadaAN , MorimotoL , BottosK , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: a randomized prospective study. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 1502. ">Rocha 2006a</a>; <a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>; <a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>) reported receiving no funding. </p> <p>Seventeen of the 51 included studies did not report potential conflicts of interest. Thirty‐one studies reported an absence of any conflict of interest (<a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a>; <a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a>; <a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0006" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of neutral and blue‐blocking intraocular lenses on circadian photoentrainment. Investigative Ophthalmology and Visual Science2014; Vol. 55, issue 13:4184. ">Brøndsted 2014</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0037" title="RochaKM , NoseW , ChalitaMR , YamadaAC , BottosK , BottosJ , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: randomized prospective study. American Academy of Ophthalmology. 2006:200. ">Rocha 2006b</a>; <a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>; <a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>; <a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a>; <a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>). Three studies (<a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>) declared that one or more of their authors were employees of the IOL manufacturer that funded the trial. </p> </section> </section> <section id="CD011977-sec-0086"> <h4 class="title">Excluded studies</h4> <p>We excluded 32 studies from the review, after assessing full‐text reports. The reasons for excluding these studies are detailed in the <a href="./references#CD011977-sec-0132" title="">Characteristics of excluded studies</a> table. Sixteen trials (<a href="./references#CD011977-bbs2-0052" title="AlexanderI , CuthbertsonFM , RatnarajanG , SafaR , MellingtonFE , FosterRG , et al. Impact of cataract surgery on sleep in patients receiving either ultraviolet‐blocking or blue‐filtering intraocular lens implants. Investigative Ophthalmology and Visual Science2014; Vol. 55, issue 8:4999‐5004. ">Alexander 2014</a>; <a href="./references#CD011977-bbs2-0053" title="AlfonsoJF , Fernández‐VegaL , BaamondeMB , Montés‐MicóR . Prospective visual evaluation of apodized diffractive intraocular lenses. Journal of Cataract and Refractive Surgery2007;33(7):1235‐43. ">Alfonso 2007</a>; <a href="./references#CD011977-bbs2-0056" title="CionniRJ , TsaiJH . Color perception with AcrySof natural and AcrySof single‐piece intraocular lenses under photopic and mesopic conditions. Journal of Cataract and Refractive Surgery2006;32(2):236‐42. ">Cionni 2006</a>; <a href="./references#CD011977-bbs2-0059" title="FengX , XuK , HaoY , Qi , H . Impact of blue‐light filtering intraocular lens implantation on the quality of sleep in patients after cataract surgery. Medicine2016;95(51):e5648. ">Feng 2016</a>; <a href="./references#CD011977-bbs2-0062" title="HammondBRJr , RenziLM , SachakS , BrintSF . Contralateral comparison of blue‐filtering and non‐blue‐filtering intraocular lenses: glare disability, heterochromatic contrast, and photostress recovery. Clinical Ophthalmology2010;4:1465‐73. ">Hammond 2010</a>; <a href="./references#CD011977-bbs2-0063" title="HayashiK , MasumotoM , HayashiH . All‐distance visual acuity in eyes with a nontinted or a yellow‐tinted diffractive multifocal intraocular lens. Japanese Journal of Ophthalmology2009;53(2):100‐6. ">Hayashi 2009</a>; <a href="./references#CD011977-bbs2-0065" title="LakD , LubinskiW , SylwestrzakZ , SzychZ , KarczewiczD . Comparative assessment of the course of age‐related macular degeneration in patients after phacoemulsification cataract surgery with implantation of AcrySof Natural SN 60 at and AcrySof SA 60 at lenses. Annales Academiae Medicae Stetinensis2007;53(Suppl 1):43‐7. ">Lak 2007</a>; <a href="./references#CD011977-bbs2-0066" title="LavricA , PompeMT . Do blue‐light filtering intraocular lenses affect visual function?. Optometry and Vision Science2014;91(11):1348‐54. ">Lavric 2014</a>; <a href="./references#CD011977-bbs2-0072" title="MuñozG , Belda‐SalmerónL , Albarrán‐DiegoC , Ferrer‐BlascoT , Fernández‐PorreroA . Contrast sensitivity and color perception with orange and yellow intraocular lenses. European Journal of Ophthalmology2012;22(5):769‐75. ">Munoz 2012</a>; <a href="./references#CD011977-bbs2-0073" title="NagaiH , HiranoY , YasukawaT , MoritaH , NozakiM , Wolf‐SchnurrbuschU , et al. Prevention of increased abnormal fundus autofluorescence with blue light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2015;41(9):1855‐9. ">Nagai 2015</a>; <a href="./references#CD011977-bbs2-0075" title="NishiT , TaketaniF , UedaT , OgataN . Comparisons of amplitude of pseudoaccommodation with aspheric yellow, spheric yellow, and spheric clear monofocal intraocular lenses. Clinical Ophthalmology2013;7:2159‐64. ">Nishi 2013</a>; <a href="./references#CD011977-bbs2-0076" title="Rodríguez‐GalieteroA , Montés‐MicóR , MuñozG , Albarrán‐DiegoC . Blue‐light filtering intraocular lens in patients with diabetes: contrast sensitivity and chromatic discrimination. Journal of Cataract and Refractive Surgery2005;31(11):2088‐92. ">Rodriguez‐Galietero 2005a</a>; <a href="./references#CD011977-bbs2-0078" title="ShpakAA , MaliuginBE , FadeevaTV . The effect of yellow filter intraocular lens on the macula after cataract phacoemulsification in patients with age macular degeneration. Vestnik Oftalmologii2012;128(4):48‐51. ">Shpak 2012</a>; <a href="./references#CD011977-bbs2-0080" title="SunK , HuangY , LuoS , LuQ , ZhangW , XieJ , et al. The clinical investigation of early visual function in cataract patients after implantation with aspheric intraocular lens. Eye Science2007;23(1):43‐7. ">Sun 2007</a>; <a href="./references#CD011977-bbs2-0082" title="WenHM , HanLC , CongRC , LiHX . Compare the pseudophakic accommodation of three type monofocal intraocular lens implantation eyes. International Eye Science2012;12(7):1311‐3. ">Wen 2012</a>; <a href="./references#CD011977-bbs2-0083" title="WohlfartC , TschuschnigK , FellnerP , WeissK , VidicB , El‐ShabrawiY , et al. Visual function with blue light filter IOLs. Klinische Monatsblätter für Augenheilkunde2007;224(1):23‐7. ">Wohlfart 2007</a>) adopted a non‐randomised method for allocating interventions. Twelve trials (<a href="./references#CD011977-bbs2-0054" title="ChenC , DuWJ , ShenLT , WeiQH . Comparison of the contrast vision after implanting photochromic, yellow or clear intraocular lenses. International Eye Science2013;13(5):931‐3. ">Chen 2013</a>; <a href="./references#CD011977-bbs2-0055" title='ChiosiF , GreensteinVC , BraunsteinRE , HolopigianK , SeipleW , SparrowJR . Does a "yellow" tinted IOL adversely affect scotopic and photopic visual performance?. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 304. '>Chiosi 2006</a>; <a href="./references#CD011977-bbs2-0058" title="CunhaJP , PaivaT , Castanheira‐DinisA . The eye, the intraocular lens and the circadian rhythm. Journal of Sleep Research2010;19:189. ">Cunha 2010</a>; <a href="./references#CD011977-bbs2-0060" title="GavrisM , HorgeI , MarianN , PopaD , OlaruG , StepanE . Our experience with Acrysof Natural intraocular lens. Oftalmologia2006;50(3):94‐8. ">Gavris 2006</a>; <a href="./references#CD011977-bbs2-0067" title="MayerS , WirbelauerC , HaberleH , PhamDT . Contrast vision after IOL implantation with or without blue light filter. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 1):S8. ">Mayer 2005</a>; <a href="./references#CD011977-bbs2-0068" title="MayerS , WirbelauerC , PhamDT . Functional results after intraocular lens implantation with or without blue light filter: an intraindividual comparison. Klinische Monatsblätter für Augenheilkunde2006;223(2):142‐6. ">Mayer 2006</a>; <a href="./references#CD011977-bbs2-0069" title="MesterU , KaymakH . The aspheric blue light filter IOL AcrySof IQ compared to the AcrySof SA60AT: influence of IOL power, pupil diameter, and corneal asphericity on postoperative spherical aberration. Der Ophthalmologe2008;105(11):1029‐35. ">Mester 2008b</a>; <a href="./references#CD011977-bbs2-0070" title="MesterU , KaymakH . Comparison of the AcrySof IQ aspheric blue light filter and the AcrySof SA60AT intraocular lenses. Journal of Refractive Surgery2008;24(8):817‐25. ">Mester 2008c</a>; <a href="./references#CD011977-bbs2-0071" title="MullerV , LangenbeckJ , MullerM , TetzMR . Intra‐ and interindividual comparison of spherical, aspherical, clear and yellow intraocular lenses (IOL). Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 7):S18. ">Muller 2005</a>; <a href="./references#CD011977-bbs2-0074" title="NakamuraT , KiuchiY , FukuiK , HaradaJ , FujimotoM . Improving contrast sensitivity with the Acryl‐Foldable yellow intraocular lens. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 302. ">Nakamura 2006</a>; <a href="./references#CD011977-bbs2-0077" title="Rodríguez‐GalieteroA , Montés‐MicóR , MuñozG , Albarrán‐DiegoC . Comparison of contrast sensitivity and color discrimination after clear and yellow intraocular lens implantation. Journal of Cataract and Refractive Surgery2005;31(9):1736‐40. ">Rodriguez‐Galietero 2005b</a>; <a href="./references#CD011977-bbs2-0079" title="StopyraW . Evaluation of colour vision according to type of implanted artificial foldable intraocular lens. Klinika Oczna2012;114(4):266‐9. ">Stopyra 2012</a> did not specify adopting a randomised method to allocate interventions. Four trials (<a href="./references#CD011977-bbs2-0057" title="ClarkeMP , YapM , WeatherillJR . Do intraocular lenses with ultraviolet absorbing chromophores protect against macular oedema?. Acta Ophthalmologica1989;67(5):593‐6. ">Clarke 1989</a>; <a href="./references#CD011977-bbs2-0061" title="GibsonGA , DaviesLN , WolffsohnJS . Cognitive and visual function in phakic and pseudophakic eyes: an intraocular lens filter study. Investigative Ophthalmology and Visual Science2008:ARVO E‐ abstract 3342. ">Gibson 2008</a>; <a href="./references#CD011977-bbs2-0064" title="KraffMC , SandersDR , JampolLM , LiebermanHL . Effect of an ultraviolet‐filtering intraocular lens on cystoid macular edema. Ophthalmology1985;92(3):366‐9. ">Kraff 1985</a>; <a href="./references#CD011977-bbs2-0081" title="TognettoD , TotoL , SanguinettiG , CecchiniP , VattovaniO , FilacordaS , et al. Lens epithelial cell reaction after implantation of different intraocular lens materials: two‐year results of a randomized prospective trial. Ophthalmology2003;110(10):1935‐41. ">Tognetto 2003</a>) did not meet the criteria for the type(s) of interventions being considered in this review. </p> <p>As detailed in the <a href="./references#CD011977-sec-0133" title="">Characteristics of studies awaiting classification</a>, we categorised one study (<a href="./references#CD011977-bbs2-0084" title="JiHL , XiaoW , PuW . Mesopic visual quality after three kinds of aspheric acrylic monofocal intraocular lenses. International Eye Science2013;13(8):1609‐12. ">Ji 2013</a>) as 'awaiting classification', pending its translation to identify whether it meets the inclusion criteria for the review. We were unable to source two full‐text reports of studies (<a href="./references#CD011977-bbs2-0085" title="LiHW , GuoHK , ZhangHY , JinHY , ChenYL , LiuMY . Comparative analysis of visual quality after aspheric intraocular lens implantation. International Journal of Ophthalmology2009;9(11):2092‐6. ">Li 2009</a>; <a href="./references#CD011977-bbs2-0086" title="ShiD , ZhangJS . Impact of different intraocular lens design on the wave‐front aberration of pseudophakic eyes. International Journal of Ophthalmology2008;8(1):71‐3. ">Shi 2008</a>). </p> <p>We categorised one study (<a href="./references#CD011977-bbs2-0087" title="NishiT , SaekiK , ObayashiK , MiyataK , ToneN , TsujinakaH , et al. The effect of blue‐blocking intraocular lenses on circadian biological rhythm: protocol for a randomised controlled trial (CLOCK‐IOL colour study). BMJ Open2015;5(5):e007930. ">Nishi 2015</a>) as ongoing. </p> </section> </section> <section id="CD011977-sec-0087"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD011977-fig-0002">Figure 2</a> and <a href="#CD011977-fig-0003">Figure 3</a> summarise the risk of bias assessments for studies included in this review. We have also provided information on risk of bias for individual studies are also provided in the <a href="./references#CD011977-sec-0131" title="">Characteristics of included studies</a>. We did not judge any of the 51 included studies to have a low risk of bias in all seven domains. We considered most studies to have an unclear risk of bias in at least four domains and approximately two‐thirds of the included studies to have a high risk of bias in the domains relating to ‘blinding of participants and personnel (performance bias)’ and ‘blinding of outcome assessment (detection bias)’. The vast majority of studies did not adequately describe their selection bias, ‘random sequence generation’ and ‘allocation concealment’ processes. The three studies that we considered to have the least overall risk of bias (<a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>), which we judged as ‘low’ risk in five of the seven domains, did not report quantitative data that could be included in the analysis for any of the prespecified outcomes. </p> <div class="figure" id="CD011977-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011977-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011977-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011977-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011977-sec-0088"> <h4 class="title">Allocation</h4> <p>Although all of the included studies were reported to be randomised, only four trials (<a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>), clearly detailed the method for generating a random sequence allocation, and we judged them as having a low risk of bias in this domain. Four trials did not describe how the randomisation sequence was generated, but reported an appropriate method to conceal the allocation sequence (<a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>). We considered that none of the 51 studies adequately reported both how the randomisation sequence was generated and how allocation was concealed. </p> </section> <section id="CD011977-sec-0089"> <h4 class="title">Blinding</h4> <p>With regard to performance bias, eight studies clearly specified masking study participants and study personnel (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>). For eight trials (<a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>), the study reports stated that the trials were 'double‐blind' or that participants and personnel were masked, but no details were provided with regard to how this was achieved. We therefore judged the potential risk of performance bias to be unclear in these trials. <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> reported that participants were masked to the intervention, but there was no mention of whether personnel were masked. We therefore judged the risk of performance bias in this study as unclear. For the other 34 trials, the design was either an ‘open label’ trial (<a href="./references#CD011977-bbs2-0004" title="Behrens‐BaumannW , WalterS , MullerS , KuchenbeckerJ , LindnerH . Comparison of two lOLs: Hoya AF‐ I (UV) VA6013B vs. AF‐1 (UY) YA‐60BB. American Academy of Ophthalmology. 2005:185. ">Behrens‐Baumann 2005</a>; <a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a>; <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>; <a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a>), 'patient‐masked only' (<a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>), or there was no information provided in relation to how masking may have been performed for study participants and personnel (<a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a>; <a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a>; <a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0006" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of neutral and blue‐blocking intraocular lenses on circadian photoentrainment. Investigative Ophthalmology and Visual Science2014; Vol. 55, issue 13:4184. ">Brøndsted 2014</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>; <a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0018" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue light filter: a comparison of SN60 and SA60. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 1):S15‐6. ">Hahsler 2004</a>; <a href="./references#CD011977-bbs2-0019" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue filter: SN 60/SA 60, HOYA‐YA/HOYA‐VA on the F.A.C.T. test facility. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 1):S8. ">Hahsler 2005</a>; <a href="./references#CD011977-bbs2-0021" title="HyunseokA , KimSW , KimEK , LeeAY , KimT . Comparison of an aspherical IOL with a spherical IOU wavefront analysis and visual quality. American Academy of Ophthalmology. 2007:210. ">Hyunseok 2007</a>; <a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0036" title="RochaKM , NoseW , ChalitaM , YamadaAN , MorimotoL , BottosK , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: a randomized prospective study. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 1502. ">Rocha 2006a</a>; <a href="./references#CD011977-bbs2-0037" title="RochaKM , NoseW , ChalitaMR , YamadaAC , BottosK , BottosJ , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: randomized prospective study. American Academy of Ophthalmology. 2006:200. ">Rocha 2006b</a>; <a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a>; <a href="./references#CD011977-bbs2-0042" title="SorianoES , RochaKM , NoseW , MonmotoM , ChalitaMR , ChamonW . Correlation between near vision and pupil size in aspheric and spherical IOLs. American Academy of Ophthalmology. 2006:209. ">Soriano 2006</a>; <a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a>; <a href="./references#CD011977-bbs2-0044" title="UedaT , OtaT , YukawaE , HaraY . Frequency doubling technology perimetry after clear and yellow intraocular lens implantation. American Journal of Ophthalmology2006;142(5):856‐8. ">Ueda 2006</a>; <a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a>; <a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>; <a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a>); in the absence of reporting, we assumed that masking was not performed, which constituted a high potential risk of bias. </p> <p>For masking of outcome assessors (detection bias), we judged a low risk of bias for 11 trials (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>). For six trials, the studies were described as 'double‐blind', but they did not provide any details with regard to how this was achieved. We therefore judged the potential risk of bias in this domain to be unclear (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>). We judged the other 34 included studies to have a high risk of detection bias, due to being either open label, 'patient‐masked' only or providing no information with regard to the masking of the outcome assessors. </p> </section> <section id="CD011977-sec-0090"> <h4 class="title">Incomplete outcome data</h4> <p>We judged 15 trials judged to have a low risk of attrition bias (<a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>), reporting that either there were no participants lost to follow‐up, or missing data of less than 20% (based upon a 20% attrition threshold, <a href="./references#CD011977-bbs2-0140" title="SchulzKF , GrimesDA . Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet2002;359(9308):781‐5. ">Schulz 2002</a>), and relatively equal follow‐up in both groups with no obvious reason as to why loss to follow‐up should have been related to the outcome. In 32 studies, we judged the influence of attrition bias to be unclear, as follow‐up was either not clearly stated (<a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a>; <a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a>; <a href="./references#CD011977-bbs2-0004" title="Behrens‐BaumannW , WalterS , MullerS , KuchenbeckerJ , LindnerH . Comparison of two lOLs: Hoya AF‐ I (UV) VA6013B vs. AF‐1 (UY) YA‐60BB. American Academy of Ophthalmology. 2005:185. ">Behrens‐Baumann 2005</a>; <a href="./references#CD011977-bbs2-0006" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of neutral and blue‐blocking intraocular lenses on circadian photoentrainment. Investigative Ophthalmology and Visual Science2014; Vol. 55, issue 13:4184. ">Brøndsted 2014</a>; <a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a>; <a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a>; <a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0018" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue light filter: a comparison of SN60 and SA60. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 1):S15‐6. ">Hahsler 2004</a>; <a href="./references#CD011977-bbs2-0019" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue filter: SN 60/SA 60, HOYA‐YA/HOYA‐VA on the F.A.C.T. test facility. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 1):S8. ">Hahsler 2005</a>; <a href="./references#CD011977-bbs2-0021" title="HyunseokA , KimSW , KimEK , LeeAY , KimT . Comparison of an aspherical IOL with a spherical IOU wavefront analysis and visual quality. American Academy of Ophthalmology. 2007:210. ">Hyunseok 2007</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a>; <a href="./references#CD011977-bbs2-0036" title="RochaKM , NoseW , ChalitaM , YamadaAN , MorimotoL , BottosK , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: a randomized prospective study. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 1502. ">Rocha 2006a</a>; <a href="./references#CD011977-bbs2-0037" title="RochaKM , NoseW , ChalitaMR , YamadaAC , BottosK , BottosJ , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: randomized prospective study. American Academy of Ophthalmology. 2006:200. ">Rocha 2006b</a>; <a href="./references#CD011977-bbs2-0042" title="SorianoES , RochaKM , NoseW , MonmotoM , ChalitaMR , ChamonW . Correlation between near vision and pupil size in aspheric and spherical IOLs. American Academy of Ophthalmology. 2006:209. ">Soriano 2006</a>; <a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a>; <a href="./references#CD011977-bbs2-0044" title="UedaT , OtaT , YukawaE , HaraY . Frequency doubling technology perimetry after clear and yellow intraocular lens implantation. American Journal of Ophthalmology2006;142(5):856‐8. ">Ueda 2006</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>; <a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a>; <a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a>), participants were potentially excluded due to intraoperative and/or postoperative complications (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>; <a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a>; <a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>), or where there was relatively similar follow‐up in the intervention groups but less than 80% participant retention overall (<a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>). Four studies were judged as having a high risk of attrition bias (<a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>; <a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>; <a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>) as overall participant follow‐up was less than 80%. </p> <p>None of the included studies specifically reported undertaking an intention‐to‐treat (ITT) analysis. </p> </section> <section id="CD011977-sec-0091"> <h4 class="title">Selective reporting</h4> <p>For 48 of the 51 included studies, we could not judge whether there was selective outcome reporting due to lack of access to the study protocol or a clinical trials registry entry, so we classed them as being as unclear risk of reporting bias. We judged two trials as having a low risk of reporting bias, as the outcomes in the manuscript were consistent with the relevant clinical trials registry entry on clinicaltrials.gov (<a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>). We judged one trial as having a high risk of reporting bias, as results from the "morningness‐eveningness questionnaire", listed as a secondary outcome measure on the clinicaltrials.gov entry, were not reported in the publication (<a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a>). </p> </section> <section id="CD011977-sec-0092"> <h4 class="title">Other potential sources of bias</h4> <p>For 36 of the 51 included trials we did not identify any other potential sources of bias (<a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a>; <a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a>; <a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0004" title="Behrens‐BaumannW , WalterS , MullerS , KuchenbeckerJ , LindnerH . Comparison of two lOLs: Hoya AF‐ I (UV) VA6013B vs. AF‐1 (UY) YA‐60BB. American Academy of Ophthalmology. 2005:185. ">Behrens‐Baumann 2005</a>; <a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0006" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of neutral and blue‐blocking intraocular lenses on circadian photoentrainment. Investigative Ophthalmology and Visual Science2014; Vol. 55, issue 13:4184. ">Brøndsted 2014</a>; <a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a>; <a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a>; <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a>; <a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a>; <a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a>; <a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a>; <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>; <a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>; <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a>; <a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>; <a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a>; <a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>; <a href="./references#CD011977-bbs2-0044" title="UedaT , OtaT , YukawaE , HaraY . Frequency doubling technology perimetry after clear and yellow intraocular lens implantation. American Journal of Ophthalmology2006;142(5):856‐8. ">Ueda 2006</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>; <a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a>; <a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a>; <a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a>). We judged four studies as having a high risk of other bias as a result of them being funded by industry, by the companies that manufactured the investigated IOLs (<a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a>). We judged an unclear risk of other sources of bias for nine studies, where only abstracts were available (<a href="./references#CD011977-bbs2-0018" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue light filter: a comparison of SN60 and SA60. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 1):S15‐6. ">Hahsler 2004</a>; <a href="./references#CD011977-bbs2-0019" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue filter: SN 60/SA 60, HOYA‐YA/HOYA‐VA on the F.A.C.T. test facility. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 1):S8. ">Hahsler 2005</a>; <a href="./references#CD011977-bbs2-0021" title="HyunseokA , KimSW , KimEK , LeeAY , KimT . Comparison of an aspherical IOL with a spherical IOU wavefront analysis and visual quality. American Academy of Ophthalmology. 2007:210. ">Hyunseok 2007</a>; <a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a>; <a href="./references#CD011977-bbs2-0036" title="RochaKM , NoseW , ChalitaM , YamadaAN , MorimotoL , BottosK , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: a randomized prospective study. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 1502. ">Rocha 2006a</a>; <a href="./references#CD011977-bbs2-0037" title="RochaKM , NoseW , ChalitaMR , YamadaAC , BottosK , BottosJ , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: randomized prospective study. American Academy of Ophthalmology. 2006:200. ">Rocha 2006b</a>; <a href="./references#CD011977-bbs2-0042" title="SorianoES , RochaKM , NoseW , MonmotoM , ChalitaMR , ChamonW . Correlation between near vision and pupil size in aspheric and spherical IOLs. American Academy of Ophthalmology. 2006:209. ">Soriano 2006</a>; <a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a>; <a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a>), as there was insufficient information provided to comprehensively judge this domain. For <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>, we judged the risk of other sources of bias to be unclear, as the sex distribution of the study groups at baseline was not reported, however the significance of this baseline imbalance was not clear. For <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>, we judged the risk of bias in this domain also as unclear as there was no baseline information available for participants. </p> </section> </section> <section id="CD011977-sec-0093"> <h3 class="title" id="CD011977-sec-0093">Effects of interventions</h3> <p>See: <a href="./full#CD011977-tbl-0001"><b>Summary of findings for the main comparison</b> Blue‐light filtering intraocular lenses (IOL) compared to non blue‐light filtering IOL for protecting macular health</a> </p> <p><a href="./full#CD011977-tbl-0001">summary of findings Table for the main comparison</a> summarises the effects of the intervention (blue‐light filtering IOL) compared to the comparator (non‐blue‐light filtering IOL) for prespecified outcomes. </p> <section id="CD011977-sec-0094"> <h4 class="title">Primary outcome: effect on distance best‐corrected visual acuity (BCVA)</h4> <p>A total of six studies (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>), reported data relating to the effect on distance BCVA data within six and 18 months of follow‐up; as none of the studies reported the change in distance BCVA from baseline, we utilised data reported at the end of the follow‐up period. </p> <p>Two trials were single‐eye intervention studies, with no unit‐of‐analysis issue (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>). Three trials (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>), were paired eye studies that undertook inter‐eye comparisons; for these trials, we attempted to contact the study authors via email to obtain the mean and standard deviations of the within‐pair differences in BCVA at follow‐up, however no response was received after more than one month of the email; data from these trials were not included in the meta‐analysis, due to the potential for biased estimates of variance of the outcome. One trial (<a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>), analysed data from 98 eyes of 71 participants without providing further details regarding the analysis approach; we had intended to contact the authors for details relating to the intra‐class correlation coefficient for the within‐person clustering of BCVA, however we could not find any contact details. As a result, we could not include data from this study in the meta‐analysis. </p> <p>Given the differences in study designs, we undertook a meta‐analysis for the single‐eye trials (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>; <a href="./references#CD011977-fig-0009" title="">Analysis 1.1</a>; <a href="#CD011977-fig-0004">Figure 4</a>). Pooling the results from these studies, which reported BCVA at 12 months (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>), and six months (<a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>), of follow‐up, the effect on distance BCVA was not statistically significant between blue‐light filtering IOLs and non‐blue‐light filtering IOLs (MD: ‐0.01, 95% CI ‐0.03 to 0.02, P = 0.48; n = 131 eyes, studies: 2); the level of heterogeneity between the two studies was negligible (I<sup>2</sup> = 0%). Similar findings were reported separately in the three paired‐eye trials (<a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>), and in <a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a>, which did not provide specific details regarding the unit of analysis, but appeared to be in Snellen acuity (<a href="./references#CD011977-fig-0010" title="">Analysis 1.2</a>; <a href="#CD011977-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD011977-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.1 Change in distance best‐corrected visual acuity (BCVA), between baseline and 12 months (accepting measures for 6‐18 months' follow‐up. If change in distance BCVA not reported, we have utilised data reported at the end of the follow‐up period)." data-id="CD011977-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.1 Change in distance best‐corrected visual acuity (BCVA), between baseline and 12 months (accepting measures for 6‐18 months' follow‐up. If change in distance BCVA not reported, we have utilised data reported at the end of the follow‐up period). </p> </div> </div> </div> <div class="figure" id="CD011977-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.2 Change in distance best‐corrected visual acuity (BCVA) for paired‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months' follow‐up. If change in distance BCVA was not reported, we utilised data reported at the end of the follow‐up period." data-id="CD011977-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.2 Change in distance best‐corrected visual acuity (BCVA) for paired‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months' follow‐up. If change in distance BCVA was not reported, we utilised data reported at the end of the follow‐up period. </p> </div> </div> </div> <p>We assessed the certainty of the evidence for this outcome measure as 'moderate' using the GRADE approach. </p> </section> <section id="CD011977-sec-0095"> <h4 class="title">Secondary outcome: effect on contrast sensitivity</h4> <p>Four trials (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>), reported data relating to the effect on contrast sensitivity, measured within three and nine months of follow‐up, in log Contrast Sensitivity, rather than log Contrast Threshold (%), as we had sought to capture. One study (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>), reported the change in contrast sensitivity from baseline, as measured using a Pelli Robson chart. For the remaining studies, (<a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>), data were reported at the end of the follow‐up period. <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> also used a Pelli Robson chart for measurement. <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a> quantified contrast sensitivity using the Optec 6500 Contrast Sensitivity View‐In Tester (Stereo Optical Company). <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a> used a CSV‐1000 retroilluminated contrast sensitivity chart (Vector Vision). </p> <p>Two trials (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>), were single‐eye intervention studies, with no unit‐of‐analysis issue, however we could not pool these data as standardised mean differences, because they represented change scores and final values respectively. As for the distance BCVA outcome, the two other trials (<a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>), were paired eye studies that undertook inter‐eye comparisons; for these trials, we attempted to contact the study authors via email to obtain the mean and standard deviations of the within‐pair differences at follow‐up, however no response was received after more than one month of the email; we were therefore not able to include these data in a meta‐analysis. </p> <p>The data from the single‐eye trials are presented in <a href="./references#CD011977-fig-0011" title="">Analysis 1.3</a> and <a href="#CD011977-fig-0006">Figure 6</a>. Contrast sensitivity was considered as the change from baseline at three months (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>), and the study endpoint value at six months of follow‐up (<a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>). Similar findings were reported in the results of the two paired‐eye trials (<a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-fig-0012" title="">Analysis 1.4</a>; <a href="#CD011977-fig-0007">Figure 7</a>). </p> <div class="figure" id="CD011977-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.2 Effect on photopic contrast sensitivity function, measured in log Contrast Threshold (%) using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (with an acceptable follow‐up range of 3‐9 months)." data-id="CD011977-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.2 Effect on photopic contrast sensitivity function, measured in log Contrast Threshold (%) using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (with an acceptable follow‐up range of 3‐9 months). </p> </div> </div> </div> <div class="figure" id="CD011977-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.4 Contrast sensitivity function, measured in log Contrast Sensitivity, using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (acceptable follow‐up range of 3‐9 months) [logCT]." data-id="CD011977-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.4 Contrast sensitivity function, measured in log Contrast Sensitivity, using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (acceptable follow‐up range of 3‐9 months) [logCT]. </p> </div> </div> </div> <p>We assessed the certainty of the evidence for this outcome measure as 'low' using the GRADE approach. </p> </section> <section id="CD011977-sec-0096"> <h4 class="title">Secondary outcome: effect on colour vision</h4> <p>As previously reported, we were unable to extract any relevant data for the effect on colour discrimination, measured as the proportion of eyes that had a measurable loss of colour discrimination from baseline using the Farnsworth‐Munsell 100‐hue colour test score under phototopic conditions, at six months of follow‐up; thus, we could not perform a meta‐analysis. </p> <p>Although the potential effect of the intervention on colour vision was considered in several studies, the ability to include this information was limited by the use of subjective‐reported outcomes (<a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>; <a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a>), quantitative data not being provided in the required format (<a href="./references#CD011977-bbs2-0004" title="Behrens‐BaumannW , WalterS , MullerS , KuchenbeckerJ , LindnerH . Comparison of two lOLs: Hoya AF‐ I (UV) VA6013B vs. AF‐1 (UY) YA‐60BB. American Academy of Ophthalmology. 2005:185. ">Behrens‐Baumann 2005</a>; <a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a>; <a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a>; <a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a>; <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>; <a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>; <a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a>; <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a>; <a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a>), quantification with an alternative colour vision test (Ishihara (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>), and/or Farnsworth D‐15 test (<a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a>)), or examination at a different follow‐up time point (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>). </p> <p>While most individual studies that considered effects on colour vision reported no significant difference between IOL interventions, <a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a> reported that "performance on rack 3 of the FM 100‐hue test, which contains blue disks, resulted in significantly higher mean total error scores in the yellow (blue‐light filtering) IOL group than in the other 2 IOL (photochromic and clear IOL) groups. The differences were statistically significant under mesopic (30 lux) conditions, under which photochromic IOL and clear IOL remained colorless." These findings are consistent with the findings of <a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a>, who concluded that "patients with yellow tinted IOLs made statistically significantly more mistakes in the blue range under dim light than patients with clear IOLs." </p> </section> <section id="CD011977-sec-0097"> <h4 class="title">Secondary outcome: development of late stage age‐related macular degeneration (AMD)</h4> <p>We obtained data on the development of late‐stage AMD from one trial, <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>. In this paired‐eye study, which involved the recruitment of 30 people (60 eyes), of which 25 people (50 eyes) completed the study, there were no cases of late‐stage AMD at the five year follow‐up time point. </p> <p>We assessed the certainty of the evidence for this outcome measure as 'very low' using the GRADE approach. </p> </section> <section id="CD011977-sec-0098"> <h4 class="title">Secondary outcome: development of any stage of AMD</h4> <p>Two small trials (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>), both being of a paired‐eye (intra‐individual) design, involving the recruitment of a total of 77 participants, reported data relating to the development of any stage of AMD in 144 eyes. The postoperative follow‐up period for these studies was five years (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>), and 12 months (<a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>). In both studies, there were no participants (in either the intervention of comparator groups) who developed AMD over the nominated follow‐up periods. </p> <p>We assessed the certainty of the evidence for this outcome measure as 'very low' using the GRADE approach. </p> </section> <section id="CD011977-sec-0099"> <h4 class="title">Secondary outcome: development of a pathological change at the macula</h4> <p>Three studies (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>; <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>), involving a total of 404 people (748 eyes), reported outcomes relating to the development of pathological changes at the macula, where the unit of analysis was the study eye. In <a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>, a single‐eye trial, one eye developed a cystoid macular oedema (CME) at nine months of follow‐up; this eye had received a blue‐light filtering IOL. Of note, in this study participants had a diagnosis of vitreoretinal pathology, including diabetic vitreous haemorrhage, macular hole, epiretinal membrane, or persisting macula oedema, with coexisting significant cataract. In <a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a>, both eyes received the same treatment and were analysed independently; at six months of follow‐up there were six eyes (from a total of 300 eyes) that had developed a pathological change at the macula (CME) in the blue‐light filtering IOL group and three eyes (from a total of 294 eyes) that had developed CME in the non‐blue‐light filtering IOL group. In <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>, which was a paired‐eye trial, no eyes developed a pathological macula change over the follow‐up period. Pooling the results from these three trials (<a href="./references#CD011977-fig-0013" title="">Analysis 1.5</a>; <a href="#CD011977-fig-0008">Figure 8</a>), the proportion of eyes with a finding of a pathological structural change at the macula was not statistically different between blue‐light filtering IOLs and non‐blue‐light filtering IOLs (Peto odds‐ratio: 2.21, 95% CI 0.63 to 7.68, P = 0.21, n = 808 eyes, studies: 3); the level of heterogeneity between the three studies was negligible (I<sup>2</sup> = 0%). </p> <div class="figure" id="CD011977-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.5 Proportion of eyes with a finding of pathological structural change at the macula, detected by clinical observation or optical coherence tomography or retinal fundus photography, at 12 months (acceptable follow‐up range of 6‐18 months)." data-id="CD011977-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.5 Proportion of eyes with a finding of pathological structural change at the macula, detected by clinical observation or optical coherence tomography or retinal fundus photography, at 12 months (acceptable follow‐up range of 6‐18 months). </p> </div> </div> </div> <p>In addition, in <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>, it was reported that "one participant had a clinically significant epiretinal membrane in the macula" and was excluded from the analysis; they did not specify the time point at which this was identified or the intervention group of the participant. </p> </section> <section id="CD011977-sec-0100"> <h4 class="title">Secondary outcome: effect on distance BCVA, considered as a dichotomous outcome</h4> <p>For the outcome relating to the proportion of participants who lost 15 or more letters of distance BCVA from baseline after six months of follow‐up, two small trials involving a total of 41 people (63 eyes) reported relevant data (<a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>). In both <a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> (a single‐eye study) and <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a> (a paired‐eye study), there were no eyes that lost 15 or more letters of distance BCVA from baseline BCVA in either IOL intervention group. </p> <p>We assessed the certainty of the evidence for this outcome measure as 'very low' using the GRADE approach. </p> </section> <section id="CD011977-sec-0101"> <h4 class="title">Secondary outcome: effect on reaction time</h4> <p>We obtained data on the effect on reaction time, considered as the proportion of participants who had reduced reaction times, after six months of follow‐up (with an acceptable follow‐up range of three to nine months), from one study (<a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a>). In this single‐eye trial involving a total of 59 eyes, there were no individuals that had a reduction in reaction time in either IOL intervention group at three months of follow‐up. However, this outcome should be viewed in the context that it is unclear from the study methodology whether the trial was sufficiently powered to detect a difference in reaction time between the study groups. </p> </section> <section id="CD011977-sec-0102"> <h4 class="title">Secondary outcome: level of satisfaction with visual outcome</h4> <p>We obtained data on the level of patient satisfaction with the visual outcome at six months after cataract surgery from one trial (<a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a>). In this parallel‐group trial involving 60 participants, the authors reported bilateral IOL implantation of the same IOL type, except for six participants where a blue‐light filtering IOL was implanted in one eye and a non‐blue‐light IOL was implanted in the fellow eye. The study authors reported that: "high patient satisfaction was noticed since 96.67 % of patients would implant AcrySof Natural IOL again. Only one patient would not implant this lens again due to the fact that other people could see yellow »shine« in his eye. None of the patients reported any colour perception disturbances in photopic or mesopic conditions. Out of six patients having AcrySof Natural IOL in one (eye) and standard AcrySof IOL in (the) other eye, three patients were more satisfied with (the) AcrySof Natural IOL, two of them didn't notice any difference and one of them was more satisfied with AcrySof MA60BM IOL. There was no difference in colour perception under photopic and mesopic conditions between the two eyes." </p> </section> <section id="CD011977-sec-0103"> <h4 class="title">Secondary outcome: proportion of participants with adverse events with a probable causal link with the study interventions after six months of follow‐up </h4> <p>There were no relevant data relating to the proportion of participants with adverse events with a probable casual link with the study interventions after six months of follow‐up. One study, <a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a>, which reported outcomes at three months postoperatively, described that three out of 38 participants with blue‐light filtering IOLs and two out of 36 participants with non‐blue‐light filtering IOLs reported symptoms of glare; no participants in either group reported symptoms of cyanopsia. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011977-sec-0104" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011977-sec-0104">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011977-sec-0166">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011977-sec-0104"></div> <p>Intraocular lenses (IOLs) that selectively limit the transmission of shorter‐wavelength visible light, termed blue‐light filtering IOLs, have been suggested to have a potential role in protecting the macula and possibly attenuating the development and/or progression of AMD (<a href="./references#CD011977-bbs2-0089" title="BeattyS , BoultonM , HensonD , KohHH , MurrayIJ . Macular pigment and age related macular degeneration. British Journal of Ophthalmology1999;83(7):867‐77. ">Beatty 1999</a>; <a href="./references#CD011977-bbs2-0090" title="BernsteinPS , DeloriFC , RicherS , VanKujikFJ , WenzelAJ . The value of measurement of macular carotenoid pigment optical densities and distributions in age‐related macular degeneration and other retinal disorders. Vision Research2010;50(7):716‐28. ">Bernstein 2010</a>). While the rationale for blue‐light filtering ophthalmic lenses is scientifically plausible, there has been academic debate with regard to the relative merit of these ophthalmic devices for providing protection to macular health and function (<a href="./references#CD011977-bbs2-0102" title="DownesSM . Ultraviolet or blue‐filtering intraocular lenses: what is the evidence?. Eye2016;30(2):215‐21. ">Downes 2016</a>; <a href="./references#CD011977-bbs2-0105" title="DownieLE . Blue‐light filtering ophthalmic lenses: to prescribe, or not to prescribe?. Ophthalmic and Physiological Optics2017;37(6):640‐3. ">Downie 2017</a>; <a href="./references#CD011977-bbs2-0121" title="LeeRM , LamFC , LiuCS . Blue‐blocking intraocular implants should be used routinely during phacoemulsification surgery ‐ No. Eye2012;26:1400‐1. ">Lee 2012</a>; <a href="./references#CD011977-bbs2-0129" title="MainsterMA , TurnerPL . Blue‐blocking IOLs vs. short‐wavelength visible light: hypothesis‐based vs. evidence‐based medical practice. Ophthalmology2011;118(1):1‐2. ">Mainster 2011</a>; <a href="./references#CD011977-bbs2-0144" title="SymesRJ , CuthbertsonFM . Blue‐blocking intraocular implants should be used routinely during phacoemulsification surgery‐‐yes. Eye2012;26(11):1397‐9. ">Symes 2012</a>). To date, it has been unclear whether blue‐light filtering IOLs confer any potential clinical benefits over non‐blue‐light filtering IOLs, with respect to aspects such as distance BCVA, contrast sensitivity and the development of macular pathology. Further, the potential negative effects of blue‐light filtering IOLs on functional parameters, such as colour discrimination, daytime alertness and reaction times (as a cognitive outcome variable), have been raised. </p> <section id="CD011977-sec-0105"> <h3 class="title" id="CD011977-sec-0105">Summary of main results</h3> <p>The primary objective of this review was to assess the effects of blue‐light filtering IOLs with respect to providing protection to macular health and function, in adults undergoing cataract surgery. </p> <p>We identified 51 eligible RCTs for inclusion, in which more than 3325 participants (involving more than 5000 eyes) were randomised to receive either a blue‐light filtering IOL or a non‐blue‐light filtering IOL. Based upon details provided in the included studies, the number of participants in each trial ranged from 13 to 300. The post‐surgical follow‐up period ranged from four weeks to five years. Overall, the studies' methods were not well reported, and we judged many of the 'Risk of bias' domains to be unclear. We judged the risk of performance bias and detection bias to be high in most of the included studies. We did not judge any studies to be at low risk across all 'Risk of bias' domains. </p> <p>For all of the efficacy outcomes where relevant quantitative data were available, namely distance BCVA as a continuous outcome (six trials), distance BCVA as a dichotomous outcome (two trials), contrast sensitivity (four trials), development of late‐stage AMD (one trial), development of any stage of AMD (two trials), development of a pathological change at the macula (four trials), change in reaction time (one trial) and the level of patient satisfaction with the visual outcome (one trial), there was no significant difference between the outcomes reported for blue‐light filtering IOLs versus non‐blue‐light filtering IOLs. We were able to perform meta‐analyses for outcomes relating to BCVA as a continuous outcome (two trials) and contrast sensitivity (two trials); both analyses showed no significant differences between the two types of IOLs. </p> <p>For safety outcomes, being intraoperative and postoperative complications, there was also no significant difference between the outcomes reported for blue‐light filtering IOLs versus non‐blue‐light filtering IOLs. </p> <p>Thus, based upon the current, best‐available clinical data, the evidence surrounding whether blue‐light filtering IOLs provide greater protection to macular health than non‐blue‐light filtering IOLs is inconclusive. </p> </section> <section id="CD011977-sec-0106"> <h3 class="title" id="CD011977-sec-0106">Overall completeness and applicability of evidence</h3> <p>The trials included in this review were conducted in 17 countries. However, apart from one trial conducted in Australia (<a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>), all of the included studies were undertaken in the Northern hemisphere. The trials evaluated the interventions in predominantly white and Asian populations. As it is currently unclear whether the risk of AMD is increased by exposure to sunlight (<a href="./references#CD011977-bbs2-0096" title="ChalamKV , KhetpalV , RusoviciR , BalaiyaS . A review: role of ultraviolet radiation in age‐related macular degeneration. Eye Contact Lens2011;37(4):225‐32. ">Chalam 2011</a>; <a href="./references#CD011977-bbs2-0143" title="SuiGY , LiuGC , LiuGY , GaoYY , DengY , WangWY , et al. Is sunlight exposure a risk factor for age‐related macular degeneration? A systematic review and meta‐analysis. British Journal of Ophthlamology2013;97(4):389‐94. ">Sui 2013</a>), the significance of there having been relatively less research undertaken in the Southern hemisphere on the generalisability of these findings is uncertain. </p> <p>The trials in this review enrolled participants who required cataract surgery due to age‐related lenticular opacities. It is therefore unclear whether the reported findings are generalisable to younger populations requiring cataract surgery for different clinical indications (e.g., post‐trauma, congenital cataract, etc.). A further consideration is that the length of postsurgical follow‐up in the majority of trials was less than one year, with only one small study (<a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a>), involving 60 participants, considering macular health at five years of postsurgical follow‐up. There is therefore currently insufficient evidence to determine whether blue‐light filtering IOLs confer longer‐term benefits to macular health or prevent the development and/or progression of AMD over extended time periods, or both. </p> <p>As summarised in <a href="#CD011977-tbl-0002">Table 1</a>, the included studies used a variety of different IOLs. Some of these IOLs were aspheric and others adopted a spherical design; it is possible that differences in a range of vision‐related outcomes (e.g., BCVA, contrast sensitivity) may be related to the optical design of the IOL, rather than the presence or absence of a blue‐light filtering chromophore. As there were not a sufficient number of studies to consider the potential influence of optical design in our analyses, we are unable to ascertain the potential impact of this factor on the reported outcomes. </p> <p>Due to differences in measurement technique, periods of follow‐up, data presentation (e.g. no unit of error, graphical presentation only), or a combination of some or all of these factors, we were unable to extract relevant data relating to whether blue‐light filtering IOLs affect colour perception, MPOD or reaction time (as a cognitive outcome variable). Thus, the effect of blue‐light filtering IOLs, compared with non‐blue‐light filtering IOLs, on these outcomes remains unclear. </p> <p>In relation to the reporting of adverse events, including intraoperative and postoperative complications, the study designs of several trials potentially precluded the identification of all relevant cases. Approximately one‐third of the studies in the review excluded participants with intraoperative complications. Twelve studies excluded participants with postoperative complications, three trials excluded participants with incomplete follow‐up, one trial excluded participants with reduced postoperative visual acuity and one trial excluded participants with an anticipated reduced visual acuity. As data relating to excluded participants were not consistently available, it is therefore possible that the actual number of adverse events (due to both interventions) has been underestimated. </p> <p>Differences in clinical trial design also posed a challenge for analysing the data. Although many of the included studies were single‐eye trials, there were several trials that adopted either a paired‐eye design, bilateral implantation of the same IOL where the unit of analysis was the study eye, or a combination of bilateral and unilateral IOL implantations where one eye per individual was used for inter‐group comparisons and no further information was provided regarding the unit of analysis. In these instances, we attempted to contact the study authors for further information to permit the inclusion of data from these studies into the relevant meta‐analyses, but did not receive the required information. We were thus unable to pool potentially relevant data from these studies in our meta‐analyses. </p> </section> <section id="CD011977-sec-0107"> <h3 class="title" id="CD011977-sec-0107">Quality of the evidence</h3> <p>Overall, we graded the evidence relating to the prespecified outcomes as being of moderate, low and very low certainty. The most frequent reason for downgrading, which was relevant to the primary outcome (change in distance BCVA considered as a continuous outcome) and several secondary outcomes (distance BCVA considered as a dichotomous outcome, contrast sensitivity, proportion of eyes developing AMD and/or macular pathology, rate of intraoperative complications and rate of postoperative complications), was due to risks of bias (particularly as we judged most of the trials to have uncertain or high risk of bias in the domains relating to performance bias and detection bias). </p> <p>We downgraded the certainty of evidence (to low) for the effect on contrast sensitivity, as data derived from two small trials, both of which we judged to have a high risk of bias in relation to the blinding of outcome assessors, and indirectness (they did not specify spatial frequency). </p> <p>We downgraded the certainty of evidence to very low for the effects on distance BCVA (considered as a dichotomous outcome) and proportion of eyes that developed any‐stage or late‐stage AMD, due to factors relating to imprecision (e.g. unknown risk of bias in multiple domains). </p> </section> <section id="CD011977-sec-0108"> <h3 class="title" id="CD011977-sec-0108">Potential biases in the review process</h3> <p>We followed the standard methodological procedures recommended by Cochrane in order to minimise potential biases, and were unable to identify any potential biases in the review process. </p> </section> <section id="CD011977-sec-0109"> <h3 class="title" id="CD011977-sec-0109">Agreements and disagreements with other studies or reviews</h3> <p>A previous meta‐analysis (<a href="./references#CD011977-bbs2-0152" title="ZhuXF , ZouHD , FuYF , SunQ , ZhaoNQ . Comparison of blue‐light filtering IOLs and UV light‐iltering IOLs for cataract surgery: a meta‐analysis. PloS One2012;7(3):e33013. ">Zhu 2012</a>), compared functional outcomes (as related to postoperative BCVA, contrast sensitivity and colour vision, as well as postoperative visual quality assessment and adverse visual events) with blue‐light filtering IOLs compared with UV‐filtering IOLs. Consistent with our findings, this study, which included 15 RCTs, found that there were no significant differences in postoperative mean BCVA, contrast sensitivity or overall colour vision between the two types of IOLs. Based upon pooling the data from three studies, which included both single‐eye trials and paired‐eye trials, <a href="./references#CD011977-bbs2-0152" title="ZhuXF , ZouHD , FuYF , SunQ , ZhaoNQ . Comparison of blue‐light filtering IOLs and UV light‐iltering IOLs for cataract surgery: a meta‐analysis. PloS One2012;7(3):e33013. ">Zhu 2012</a> reported that colour vision with blue‐light filtering IOLs was significantly reduced in the blue‐light spectrum under mesopic light conditions (SMD = 0.74, 95% CI 0.29, 1.18; P = 0.001). We suggest that the results of this meta‐analysis should be interpreted with caution, since it appears that the authors did not adjust for the within‐person clustering of eyes, which could potentially have resulted in biased estimates of standard errors and as a result, a biased P‐value. We acknowledge that, in the present review, we did not consider the effect of short‐wavelength absorbing IOLs on visual performance at scotopic light levels; this was considered beyond the scope of the present review, but is a relevant direction for future evaluation of the effects of these devices. </p> <p>A recent systematic review (<a href="./references#CD011977-bbs2-0120" title="LawrensonJG , HullCH , DownieLE . The effect of blue‐light blocking spectacle lenses on visual performance, macular health and the sleep‐wake cycle: a systematic review of the literature. Ophthalmic and Physiological Optics2017;37(6):644‐54. ">Lawrenson 2017</a>) that considered the effects of blue‐light filtering spectacle lenses on visual performance, macular health and the sleep‐wake cycle, concluded that a lack of high‐quality evidence was identified to support the use of blue‐blocking spectacle lenses for the general population to improve visual performance or sleep quality, alleviate eye fatigue or conserve macular health. These findings, relating to outcomes measuring visual performance and macular health with spectacle lenses, are consistent with the outcomes reported for IOLs in the present review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011977-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD011977-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011977-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011977-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.1 Change in distance best‐corrected visual acuity (BCVA), between baseline and 12 months (accepting measures for 6‐18 months' follow‐up. If change in distance BCVA not reported, we have utilised data reported at the end of the follow‐up period)." data-id="CD011977-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.1 Change in distance best‐corrected visual acuity (BCVA), between baseline and 12 months (accepting measures for 6‐18 months' follow‐up. If change in distance BCVA not reported, we have utilised data reported at the end of the follow‐up period). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.2 Change in distance best‐corrected visual acuity (BCVA) for paired‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months' follow‐up. If change in distance BCVA was not reported, we utilised data reported at the end of the follow‐up period." data-id="CD011977-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.2 Change in distance best‐corrected visual acuity (BCVA) for paired‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months' follow‐up. If change in distance BCVA was not reported, we utilised data reported at the end of the follow‐up period. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.2 Effect on photopic contrast sensitivity function, measured in log Contrast Threshold (%) using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (with an acceptable follow‐up range of 3‐9 months)." data-id="CD011977-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.2 Effect on photopic contrast sensitivity function, measured in log Contrast Threshold (%) using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (with an acceptable follow‐up range of 3‐9 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.4 Contrast sensitivity function, measured in log Contrast Sensitivity, using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (acceptable follow‐up range of 3‐9 months) [logCT]." data-id="CD011977-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.4 Contrast sensitivity function, measured in log Contrast Sensitivity, using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (acceptable follow‐up range of 3‐9 months) [logCT]. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.5 Proportion of eyes with a finding of pathological structural change at the macula, detected by clinical observation or optical coherence tomography or retinal fundus photography, at 12 months (acceptable follow‐up range of 6‐18 months)." data-id="CD011977-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison 1. Blue‐light filtering IOL vs non‐blue‐light filtering IOL, outcome: 1.5 Proportion of eyes with a finding of pathological structural change at the macula, detected by clinical observation or optical coherence tomography or retinal fundus photography, at 12 months (acceptable follow‐up range of 6‐18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 1 Change in distance best‐corrected visual acuity (BCVA) for single‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months' follow‐up). If studies did not report change in distance BCVA, we utilised data reported at the end of the follow‐up period.." data-id="CD011977-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 1 Change in distance best‐corrected visual acuity (BCVA) for single‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months' follow‐up). If studies did not report change in distance BCVA, we utilised data reported at the end of the follow‐up period.. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/references#CD011977-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 2 Change in distance best‐corrected visual acuity (BCVA) for paired‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months follow‐up. If change in distance BCVA was not reported, we utilised data reported at the end of the follow‐up period.." data-id="CD011977-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 2 Change in distance best‐corrected visual acuity (BCVA) for paired‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months follow‐up. If change in distance BCVA was not reported, we utilised data reported at the end of the follow‐up period.. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/references#CD011977-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 3 Contrast sensitivity, measured in log Contrast Sensitivity at 6 months (acceptable follow‐up range of 3‐9 months)." data-id="CD011977-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 3 Contrast sensitivity, measured in log Contrast Sensitivity at 6 months (acceptable follow‐up range of 3‐9 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/references#CD011977-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 4 Contrast sensitivity function, measured in log Contrast Sensitivity, using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (acceptable follow‐up range of 3‐9 months; logCT)." data-id="CD011977-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 4 Contrast sensitivity function, measured in log Contrast Sensitivity, using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (acceptable follow‐up range of 3‐9 months; logCT). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/references#CD011977-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011977-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/urn:x-wiley:14651858:media:CD011977:CD011977-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_t/tCD011977-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 5 Proportion of eyes with a finding of pathological structural change at the macula, detected by clinical observation or OCT or retinal fundus photography, at 12 months (acceptable follow‐up range of 6‐18 months)." data-id="CD011977-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Blue‐light filtering IOL vs non‐blue‐light filtering IOL, Outcome 5 Proportion of eyes with a finding of pathological structural change at the macula, detected by clinical observation or OCT or retinal fundus photography, at 12 months (acceptable follow‐up range of 6‐18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/references#CD011977-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/media/CDSR/CD011977/image_n/nCD011977-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011977-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Blue‐light filtering intraocular lenses (IOL) compared to non blue‐light filtering IOL for protecting macular health</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Blue‐light filtering IOL compared to non‐blue‐light filtering IOL for protecting macular health</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults undergoing cataract surgery with IOL implantation<br/> <b>Setting:</b> eye hospitals<br/> <b>Intervention:</b> blue‐light filtering IOL<br/> <b>Comparison:</b> non‐blue‐light filtering IOL </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with non‐blue‐light filtering IOL</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with blue‐light filtering IOL</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in distance BCVA, between baseline and 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in distance BCVA between baseline and 12 months was 0 logMAR</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 logMAR lower<br/> (0.03 lower to 0.02 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>131<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower BCVA (in logMAR) indicates a higher level of visual acuity. Studies in this analysis reported data at the end of the follow‐up period rather than change from baseline. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Distance BCVA, considered as a dichotomous outcome (being the proportion of eyes that experienced loss of 15 or more letters from baseline BCVA), at six months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no eyes, in either intervention group that had a loss of 15 or more letters from baseline BCVA. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Contrast sensitivity function, measured in log Contrast Sensitivity at six months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relevant combinable data available for this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colour discrimination, measured as the proportion of eyes that had a measurable loss from baseline using Farnsworth‐Munsell 100‐hue colour test score under photopic conditions at six months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relevant combinable data available for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants with adverse events with a probable causal link with the study interventions at six months follow‐up </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No relevant combinable data available for this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of eyes that developed late‐stage AMD, being CNV and/or GA, at three years of follow‐up </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the 1 trial (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>) there were no eyes, in either intervention group that developed late‐stage AMD at five years of follow‐up. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of eyes that developed any stage of AMD at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>144<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In both studies, there were no eyes, in either intervention group that developed any stage of AMD over the nominated follow‐up period. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>AMD</b> : age‐related macular degeneration; <b>BCVA</b> : best‐corrected visual acuity; <b>CI:</b> confidence interval; <b>CNV</b> : choroidal neovascularisation; <b>GA</b> : geographic atrophy; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High‐certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate‐certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low‐certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low‐certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded for risk of bias (‐1). Data derive from two relatively small studies, with one (<a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>) judged to have a high risk of bias in both masking domains, and the other (<a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a>) having an unclear risk of bias in most domains.<br/> <sup>b</sup>Downgraded for imprecision (‐2). <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a> excluded participants with surgical or postoperative complications, including vitreous loss, capsule tears or prolonged intraocular inflammation from the analysis, and hence did not capture these outcomes (which may affect BCVA) in this study. In addition, there were no events in either study group.<br/> <sup>c</sup>Downgraded for risk of bias (‐1). Data derive from two relatively small studies (<a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a>; <a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a>), which both had an unclear risk of bias in at least three key domains.<br/> <sup>d</sup>Downgraded for risk of bias (‐1) and imprecision (‐2). Data derive from one small trial involving 60 participants (<a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a>), with an unknown risk of bias in multiple domains. In this trial, there were no events in either study group.<br/> <sup>e</sup>Downgraded for risk of bias (‐2) and imprecision (‐1). Data derive from two small trials (<a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a>; <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a>). The <a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a> study has an unknown risk of bias in multiple domains, and we judged <a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a> as having a high risk of bias in multiple domains, including performance bias and detection bias. In both trials, there were no events in either study group. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Blue‐light filtering intraocular lenses (IOL) compared to non blue‐light filtering IOL for protecting macular health</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011977-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Details of the intraocular lenses (IOLs) used as interventions in each study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Blue‐light filtering IOL name(s)<sup>a</sup> (Manufacturer)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Non‐blue‐light filtering IOL name(s)<sup>a</sup><br/> (Manufacturer)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0001" title="AoseM , MatsushimaH , NagataM , MatuiE , ObaraY , YoshidaS , et al. Characteristics of different types of hydrophobic acrylic intraocular lenses and clinical evaluation during early postoperative period. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 610. ">Aose 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon) or AcrySof MA60BM (Alcon) or VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or PC4406 (Optech)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof MA60BM (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0004" title="Behrens‐BaumannW , WalterS , MullerS , KuchenbeckerJ , LindnerH . Comparison of two lOLs: Hoya AF‐ I (UV) VA6013B vs. AF‐1 (UY) YA‐60BB. American Academy of Ophthalmology. 2005:185. ">Behrens‐Baumann 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0005" title="BhattacharjeeH , BhattacharjeeK , MedhiJ . Visual performance: comparison of foldable intraocular lenses. Journal of Cataract and Refractive Surgery2006;32(3):451‐5. ">Bhattacharjee 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0006" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of neutral and blue‐blocking intraocular lenses on circadian photoentrainment. Investigative Ophthalmology and Visual Science2014; Vol. 55, issue 13:4184. ">Brøndsted 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AMO ZCBOO (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0008" title="BrøndstedAE , HaargaardB , SanderB , Lund‐AndersenH , JennumP , KesselL . The effect of blue‐blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Opthalmologica2017;95(4):344‐51. ">Brøndsted 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AMO ZCBOO (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar AR40e (Abbott Medical Optics) or Tecnis Z9000 (Abbott Medical Optics) or Sofport L161AO (Bausch &amp; Lomb) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar AR40e (Abbott Medical Optics) or Tecnis Z9000 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0011" title="CionniRJ . Clinical study results of the AcrySof Natural intraocular lens. American Academy of Ophthalmology. 2003:130. ">Cionni 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SB30AL (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA30AL (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0012" title="CristobalJA , SierraJ , MartinJ , RodriguezNA , AscasoJ . Intraocular lenses with blue light filter. Archivos de la Sociedad Espanola de Oftalmologia2005;80(4):245‐9. ">Cristobal 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9001 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon) or AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9000 (Abbott Medical Optics) or Cee On Edge (Abbott Medical Optics) or Akreos AO (Bausch &amp; Lomb) or Akreos Adapt (Bausch &amp; Lomb) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0015" title="EspindleD , CrawfordB , MaxwellA , RajagopalanK , BarnesR , HarrisB , et al. Quality‐of‐life improvements in cataract patients with bilateral blue light‐filtering intraocular lenses: clinical trial. Journal of Cataract and Refractive Surgery2005;31(10):1952‐9. ">Espindle 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof single‐piece (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Akreos Fit (Bausch &amp; Lomb) or Akreos AO (Bausch &amp; Lomb) or AcrySof SA60AT as described in the methods (but appears to be inadvertently described as the MA60AC in the reporting of the results) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural (Alcon) or AF‐1 UY (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof single‐piece (Alcon) or AF‐1 UV (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0018" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue light filter: a comparison of SN60 and SA60. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 1):S15‐6. ">Hahsler 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SN60 (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SA60 (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0019" title="HahslerB , LackingerB , KlemenU . Contrast sensitivity in IOL with blue filter: SN 60/SA 60, HOYA‐YA/HOYA‐VA on the F.A.C.T. test facility. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 1):S8. ">Hahsler 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA (Hoya) or SN60 (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA (Hoya) or SA60 (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0021" title="HyunseokA , KimSW , KimEK , LeeAY , KimT . Comparison of an aspherical IOL with a spherical IOU wavefront analysis and visual quality. American Academy of Ophthalmology. 2007:210. ">Hyunseok 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis ZA9003 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0022" title="Kara‐JúniorN , JardimJL , deOliveira LemeE , Dall'ColM , SusannaRJr . Effect of the AcrySof Natural intraocular lens on blue‐yellow perimetry. Journal of Cataract and Refractive Surgery2006;32(8):1328‐30. ">Kara Júnior 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof MA30AC (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0024" title="KennisH , HuygensM , CallebautF . Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bulletin de la Societe Belge d'Ophtalmologie2004;2004(294):49‐58. ">Kennis 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9000 (Pfizer) or Opti‐Edge (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OII Biovue3 (BioVue) or YA60BBR (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9003 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0027" title="KuchenbeckerJ , MullerS , WalterS , LindnerH , Behrens‐BaumannW . The comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2004;221(Suppl 5):S11‐2. ">Kuchenbecker 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof single‐piece SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural IOL SB30AL (Alcon) (the current marketed version of this lens is the SN60AT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA30AL (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0030" title="MesterU , HolzF , KohnenT , LohmannC , TetzM . Intraindividual comparison of a blue‐light filter on visual function: AF‐1 (UY) versus AF‐1 (UV) intraocular lens. Journal of Cataract and Refractive Surgery2008;34(4):608‐15. ">Mester 2008a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UY (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UV (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof MA60AC (Alcon) or AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0032" title="Neumaier‐AmmererB , FelkeS , HagenS , HaasP , ZeilerF , MaulerH , et al. Comparison of visual performance with blue light‐filtering and ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2010;36(12):2073‐9. ">Neumaier‐Ammerer 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF1 UY (Hoya) or AcrySof SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF1 UV (Hoya) or AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0033" title="NolanJM , O'ReillyP , LoughmanJ , StackJ , LoaneE , ConnollyE , et al. Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery. Investigative Ophthalmology and Visual Science2009;50(10):4777‐85. ">Nolan 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60AT (Alcon) or AcrySof SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0036" title="RochaKM , NoseW , ChalitaM , YamadaAN , MorimotoL , BottosK , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: a randomized prospective study. Investigative Ophthalmology and Visual Science2006; Vol. 47:ARVO E‐abstract 1502. ">Rocha 2006a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ (Alcon) or AcrySof Natural (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0037" title="RochaKM , NoseW , ChalitaMR , YamadaAC , BottosK , BottosJ , et al. Wavefront analysis and contrast sensitivity of aspheric and spherical IOLs: randomized prospective study. American Academy of Ophthalmology. 2006:200. ">Rocha 2006b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ (Alcon) or AcrySof Natural (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0038" title="RochaKM , SorianoES , ChamonW , ChalitaMR , NoséW . Spherical aberration and depth of focus in eyes implanted with aspheric and spherical intraocular lenses: a prospective randomized study. Ophthalmology2007;114(11):2050‐4. ">Rocha 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof IQ (Alcon) or AcrySof SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar AR40 (Allergan)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0039" title="SchmackI , SchimpfM , StolzenbergA , Conrad‐HengererI , HengererFH , DickHB . Visual quality assessment in patients with orange‐tinted blue light‐filtering and clear ultraviolet light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2012;38(5):823‐32. ">Schmack 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oculaid PC 440Y Orange Series (Ophtec BV)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oculaid PC 430Y Elite Series (Ophtec BV)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UY (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UV (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0041" title="SchmollC , KhanA , AspinallP , GoudieC , KoayP , TendoC , et al. New light for old eyes: comparing melanopsin‐mediated non‐visual benefits of blue‐light and UV‐blocking intraocular lenses. British Journal of Ophthalmology2014;98(1):124‐8. ">Schmoll 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis ZCB (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0042" title="SorianoES , RochaKM , NoseW , MonmotoM , ChalitaMR , ChamonW . Correlation between near vision and pupil size in aspheric and spherical IOLs. American Academy of Ophthalmology. 2006:209. ">Soriano 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60AT (Alcon) or AcrySof SN60WF (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensar (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0043" title="UedaT , TaguchiY , TsukaharaM , YamamotoY , KoideR . Retinal light damage control by blue light‐absorbing intraocular lens. Investigative Ophthalmology and Visual Science2005; Vol. 46:ARVO E‐abstract 808. ">Ueda 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ENV‐13 (Menicon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ES‐13 (Menicon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0044" title="UedaT , OtaT , YukawaE , HaraY . Frequency doubling technology perimetry after clear and yellow intraocular lens implantation. American Journal of Ophthalmology2006;142(5):856‐8. ">Ueda 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof Natural SN60AT (Alcon)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SA60AT (Alcon)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0046" title="WalterS , KuchenbeckerJ , MullerS , Behrens‐BaumannW . A comparison of two intraocular lenses: Hoya AF‐1 (UV) VA‐60BB and AF‐1 (UY) YA‐60BB ‐ preliminary results. Klinische Monatsblatter fur Augenheilkunde2005;222(Suppl 6):S7‐8. ">Walter 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AF‐1 UV‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AY‐1 UY (Hoya) or Arium Matrix Model 4000 (Medennium)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MC611MI (HumanOptics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0048" title="WirtitschMG , SchmidingerG , PrskavecM , RubeyM , SkorpikF , HeinzeG , et al. Influence of blue‐light‐filtering intraocular lenses on color perception and contrast acuity. Ophthalmology2009;116(1):39‐45. ">Wirtitsch 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>YA‐60BB (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VA‐60BB (Hoya)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0049" title="YamaguchiT , NegishiK , OnoT , ToriiH , DogruM , YamaguchiK , et al. Feasibility of spherical aberration correction with aspheric intraocular lenses in cataract surgery based on individual pupil diameter. Journal of Cataract and Refractive Surgery2009;35(10):1725‐33. ">Yamaguchi 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60WF (Alcon) or AcrySof SN60AT (Alcon) or Py60AD (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9003 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AcrySof SN60WF (Alcon) or AcrySof SN60AT (Alcon) or Py60AD (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tecnis Z9003 (Abbott Medical Optics)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0051" title="YuanZ , ReinachP , Yuan , J . Contrast sensitivity and color vision with a yellow intraocular lens. American Journal of Ophthalmology2004;138(1):138‐40. ">Yuan 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported (Hoya)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported (not reported)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><sup>a</sup>Details of the interventions are provided as per the details available in the included studies. <br/> <sup>b</sup><a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a>, reported two‐year follow‐up data for four out of five of the intervention groups from the <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a> study (data from the Sofport L161AO group were not provided, although no explanation was provided). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Details of the intraocular lenses (IOLs) used as interventions in each study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011977-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Adverse effects: intraoperative complications</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study population:</b> </p> <p><b>number of participants (number of eyes)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of intraoperative complication(s)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Details of intraoperative complication(s)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOLs: n = 65 (65); this group combined individuals assigned to 2 different blue‐light filtering IOLs </p> <p>Non‐blue‐light filtering IOL: n = 33 (33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (60)</p> <p>Non‐blue‐light filtering IOL: n = 30 (60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 50 (100); this group combined individuals assigned to 2 different blue‐light filtering IOLs </p> <p>Non‐blue‐light filtering IOL: n = 75 (150); this group combined individuals assigned to 3 different non‐blue‐light filtering IOLs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 39 (41)</p> <p>Non‐blue‐light filtering IOL: n = 18 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0014" title="CuthbertsonFM , DhingraS , BenjaminL . Objective and subjective outcomes in comparing three different aspheric intraocular lens implants with their spherical counterparts. Eye2009;23(4):877‐83. ">Cuthbertson 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall: n = 31 (31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One participant developed endophthalmitis and was removed from the trial, being replaced (after re‐randomisation) by another individual. There was one anterior capsular rim tear and one posterior capsule tear without vitreous loss. No details were provided in relation to which group(s) the adverse events occurred in. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 27 (27)</p> <p>Non‐blue‐light filtering IOL: n = 52 (77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (30)</p> <p>Non‐blue‐light filtering IOL: n = 30 (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = ? (42)</p> <p>Non‐blue‐light filtering IOL: n = ? (26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 23 (23)</p> <p>Non‐blue‐light filtering IOL: n = 16 (16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 9 (9)</p> <p>Non‐blue‐light filtering IOL: n = 10 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 150 (300)</p> <p>Non‐blue‐light filtering IOL: n = 147 (294)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 1</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There was one case of lens dislocation during surgery in the blue‐light filtering IOL group, in a case in which a posterior capsule rupture had occurred during cataract extraction. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 19 (19)</p> <p>Non‐blue‐light filtering IOL: n = 40 (40); this group combined individuals assigned to 2 different non‐blue‐light filtering IOLs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 2</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In the blue‐light filtering IOL lens group "two IOLs were placed with 1 haptic in the capsular bag and 1 haptic outside the capsular bag; these 2 patients were also excluded from the final statistical analysis." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0034" title="PanditaD , RajSM , VasavadaVA , VasavadaVA , KaziNS , VasavadaAR . Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. Journal of Cataract and Refractive Surgery2007;33(4):603‐10. ">Pandita 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 73 (73); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 36 (36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0035" title="RajSM , VasavadaAR , NanavatyMA . AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. Journal of Cataract and Refractive Surgery2005;31(12):2324‐8. ">Raj 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (30)</p> <p>Non‐blue‐light filtering IOL: n = 30 (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 31 (31)</p> <p>Non‐blue‐light filtering IOL: n = 31 (31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 19 (25)</p> <p>Non‐blue‐light filtering IOL: n = 18 (27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not applicable</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><b>IOL</b>: intraocular lens </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Adverse effects: intraoperative complications</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011977-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Adverse effects: postoperative complications and Nd:YAG capsulotomies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study population: number of participants (number of eyes)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of postoperative complication(s)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Details of postoperative complication(s)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0002" title="BandyopadhyayS , SahaM , ChakrabartiA , SinhaA . Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation. International Ophthalmology2016;36(3):313‐8. ">Bandyopadhyay 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOLs: n = 65 (65); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 33 (33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at four weeks of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0003" title="BarisićA , DekarisI , GabrićN , BosnarD , LazićR , MartinovićZK , et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Collegium Antropologicum2007;31(Suppl 1):57‐60. ">Barisic 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (60)</p> <p>Non‐blue‐light filtering IOL: n = 30 (60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 3 eyes</p> <p>Non‐blue‐light filtering IOL: n = 4 eyes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Although the study authors reported that "there were no postoperative complications", n = 3 eyes from the blue‐light filtering IOL group and n = 4 eyes from the non‐blue‐light filtering IOL group required Nd:YAG capsulotomy at six months of follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0007" title="BrøndstedAE , SanderB , HaargaardB , Lund‐AndersenH , JennumP , GammeltoftS , et al. The effect of cataract surgery on circadian photoentrainment: a randomized trial of blue‐blocking versus neutral intraocular lenses. Ophthalmology2015;122(10):2115‐24. ">Brøndsted 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 38 (38)</p> <p>Non‐blue‐light filtering IOL: n = 35 (35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at six months of follow‐up.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 50 (100); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 75 (150); this group combined individuals assigned to three different non‐blue‐light filtering IOLs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at two months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0010" title="CaporossiA , CaspriniF , MartoneG , BalestrazziA , TosiGM , CiompiL . Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. Journal of Refractive Surgery2009;25(7):578‐90. ">Caporossi 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 50 (100); this group combined individuals assigned to 2 different blue‐light filtering IOLs </p> <p>Non‐blue‐light filtering IOL: n = 50 (100); this group combined individuals assigned to 2 different non‐blue‐light filtering IOLs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 1 for Nd:YAG capsulotomy</p> <p>Non‐blue‐light filtering IOL: n = 1 for Nd:YAG capsulotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This study reports the two‐year follow‐up data for a subset of participants from <a href="./references#CD011977-bbs2-0009" title="CaporossiA , MartoneG , CaspriniF , RapisardaL . Prospective randomized study of clinical performance of 3 aspheric and 2 spherical intraocular lenses in 250 eyes. Journal of Refractive Surgery2007;23(7):639‐48. ">Caporossi 2007</a>. The study authors reported that "patients who underwent a capsulotomy before two‐year follow‐up (two patients) were excluded as it was not possible to perform aberrometric analysis. Two Nd:YAG laser capsulotomies were required in two patients who had AcrySof SN60AT IOL (blue‐light filtering IOL) and Tecnis Z9000 IOL (non‐blue‐light filtering IOL) implantation." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0013" title="CuiH , HuR , ZhangY , LouD . Comparison of pseudophakic visual quality in spherical and aspherical intraocular lenses. Canadian Journal of Ophthalmology2009;44(3):274‐8. ">Cui 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 39 (41); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 18 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at two months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0016" title="EspíndolaRF , SanthiagoMR , Kara‐JúniorN . Effect of aspherical and yellow tinted intraocular lens on blue‐on‐yellow perimetry. Arquivos Brasileiros de Oftalmologia2012;75(5):316‐9. ">Espíndola 2012a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 27 (27)</p> <p>Non‐blue‐light filtering IOL: n = 52 (77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none for glaucoma or Nd:YAG capsulotomy</p> <p>Non‐blue‐light filtering IOL: none for glaucoma or Nd:YAG capsulotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The study authors reported that "at two years after surgery, all lenses were well centered and there was no evidence of posterior capsule opacity or glaucoma." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0017" title="FalknerCI , BinderS . UV‐filter IOL versus yellow blue light‐filter IOL in combined cataract surgery with vitrectomy: a prospective randomized clinical trial. Investigative Ophthalmology and Visual ScienceARVO E‐abstract 1484. Falkner‐RadlerCI , BeneschT , BinderS . Blue light‐filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. American Journal of Ophthalmology2008;145(3):499‐503. ">Falkner Radler 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (30)</p> <p>Non‐blue‐light filtering IOL: n = 30 (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 3 eyes</p> <p>Non‐blue‐light filtering IOL: n = 1 eye</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL:</p> <p>n = 1 postoperative iris capture,</p> <p>n = 1 spontaneously reabsorbed vitreous haemorrhage,</p> <p>n = 1 cystoid macular oedema at nine months after surgery</p> <p>Non‐blue‐light filtering IOL: n = 1 postoperative iris capture</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0026" title="KimJH , KimNR , LeeES , RhoS , KangSY , KimCY . Influence of blue light‐filtering intraocular lenses on retinal nerve fiber layer measurements by spectral‐domain optical coherence tomography. Current Eye Research2011;36(10):937‐42. ">Kim 2011b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 23 (23)</p> <p>Non‐blue‐light filtering IOL: n = 16 (16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at eight weeks of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0020" title="HayashiK , HayashiH . Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non‐tinted intraocular lenses. British Journal of Ophthalmology2006;90(8):1019‐23. ">Hayashi 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 38 (38)</p> <p>Non‐blue‐light filtering IOL: n = 36 (36)</p> <p>(In both groups, data were obtained from both eyes and averaged)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Glare symptoms </p> <p>Blue‐light filtering IOL: n = 3 participants</p> <p>Non‐blue‐light filtering IOL: n = 2 participants</p> <p>Cyanopsia </p> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative complications (as measured by participant report of glare symptoms and cyanopsia) at three months after surgery </p> <p>One participant was reported to have a clinically significant epiretinal membrane in the macula (it is unclear which group the participant belonged to) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0023" title="Kara‐JuniorN , EspindolaRF , GomesBA , VenturaB , SmadjaD , SanthiagoMR . Effects of blue light‐filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long‐term follow‐up. Journal of Cataract and Refractive Surgery2011;37(12):2115‐9. ">Kara Junior 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 30 (30)</p> <p>Non‐blue‐light filtering IOL: n = 30 (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Three patients required neodymium:YAG laser capsulotomy for posterior capsule opacification," however group allocations were not specified. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three participants (although this was not distinguished by the IOL intervention) at five years of follow‐up </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0025" title="KimJY , ChoiJA , NaKS , JooCK . The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery. Korean Journal of Ophthalmology2011;25(1):29‐32. ">Kim 2011a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 23 (23)</p> <p>Non‐blue‐light filtering IOL: n = 16 (16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at eight weeks of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0028" title="LeibovitchI , LaiT , PorterN , PietrisG , NewlandH , SelvaD . Visual outcomes with the yellow intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):95‐9. ">Leibovitch 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 9 (9)</p> <p>Non‐blue‐light filtering IOL: n = 10 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at six months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0029" title="MarshallJ , CionniRJ , DavisonJ , ErnestP , LehmannR , MaxwellWA , et al. Clinical results of the blue‐light filtering AcrySof Natural foldable acrylic intraocular lens. Journal of Cataract and Refractive Surgery2005;31(12):2319‐23. ">Marshall 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 150 (300)</p> <p>Non‐blue‐light filtering IOL: n = 147 (294)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 12</p> <p>Non‐blue‐light filtering IOL: n = 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At six months of follow‐up, in the blue‐light filtering IOL group, six eyes developed cystoid macula oedema and six eyes required secondary surgical intervention; none of the occurrences were considered IOL‐related. </p> <p>At six months of follow‐up, in the non‐blue‐light filtering IOL group, three eyes developed cystoid macula oedema and three eyes required secondary surgical intervention; none of the occurrences were considered IOL‐related. </p> <p>The study authors stated that "no Nd:YAG capsulotomy was performed in the first‐eye subgroup in either the test or control groups throughout the study period." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0031" title="MonnetD , TépenierL , BrézinAP . Objective assessment of inflammation after cataract surgery: comparison of 3 similar intraocular lens models. Journal of Cataract and Refractive Surgery2009;35(4):677‐81. ">Monnet 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 19 (19)</p> <p>Non‐blue‐light filtering IOL: n = 40 (40); this group combined individuals assigned to 2 different non‐blue‐light filtering IOLs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at three months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0040" title="SchmidingerG , MenapaceR , PiehS . Intraindividual comparison of color contrast sensitivity in patients with clear and blue‐light‐filtering intraocular lenses. Journal of Cataract and Refractive Surgery2008;34(5):769‐73. ">Schmidinger 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 31 (31)</p> <p>Non‐blue‐light filtering IOL: n = 31 (31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at three months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0047" title="WangH , WangJ , FanW , WangW . Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions. Journal of Cataract and Refractive Surgery2010;36(12):2080‐6. ">Wang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 80 (80); this group combined individuals assigned to 2 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = 38 (38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None at 3 months of follow‐up</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0045" title="VuoriML , MantyjarviM . Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmologica Scandinavica2006;84(1):92‐4. ">Vuori 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = 19 (25)</p> <p>Non‐blue‐light filtering IOL: n = 18 (27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The study authors stated that "in the biomicroscopic examination (at one month postoperatively) the posterior capsule appeared clear in all test eyes." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011977-bbs2-0050" title="YamaguchiT , NegishiK , OhnumaK , TsubotaK . Correlation between contrast sensitivity and higher‐order aberration based on pupil diameter after cataract surgery. Clinical Ophthalmology2011;5(1):1701‐7. ">Yamaguchi 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: n = ? (120); this group combined individuals assigned to 3 different blue‐light filtering IOLs. </p> <p>Non‐blue‐light filtering IOL: n = ? (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blue‐light filtering IOL: none</p> <p>Non‐blue‐light filtering IOL: none</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported at one month of follow‐up</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><b>IOL</b>: intraocular lens </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Adverse effects: postoperative complications and Nd:YAG capsulotomies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/full#CD011977-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011977-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Blue‐light filtering IOL vs non‐blue‐light filtering IOL</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in distance best‐corrected visual acuity (BCVA) for single‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months' follow‐up). If studies did not report change in distance BCVA, we utilised data reported at the end of the follow‐up period. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in distance best‐corrected visual acuity (BCVA) for paired‐eye trials, between baseline and 12 months (accepted measures for 6‐18 months follow‐up. If change in distance BCVA was not reported, we utilised data reported at the end of the follow‐up period. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Contrast sensitivity, measured in log Contrast Sensitivity at 6 months (acceptable follow‐up range of 3‐9 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.14, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Contrast sensitivity function, measured in log Contrast Sensitivity, using the mid‐range of the available spatial frequencies (between 6‐12 cycles/deg) at 6 months (acceptable follow‐up range of 3‐9 months; logCT) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Proportion of eyes with a finding of pathological structural change at the macula, detected by clinical observation or OCT or retinal fundus photography, at 12 months (acceptable follow‐up range of 6‐18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>808</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [0.63, 7.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Blue‐light filtering IOL vs non‐blue‐light filtering IOL</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011977.pub2/references#CD011977-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011977.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011977-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011977-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011977-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD011977-note-0015">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011977-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD011977-note-0003">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD011977-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011977-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011977\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011977\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011977\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011977\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011977\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011977.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011977.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011977.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011977.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011977.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728303429"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011977.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728303434"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011977.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec120fb1ef46e',t:'MTc0MDcyODMwMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 